Cerus Corporation
(NASDAQ:CERS)

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication is designed to reduce blood-borne pathogens in donated blood com...

Website: http://www.cerus.com

Founded: 1991

Full Time Employees: 254

Sector: Healthcare

Industry: Biotechnology

Healthcare

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-09-30	2003-06-30	2003-03-31	2002-09-30	2002-06-30	2002-03-31	2001-09-30	2001-06-30	2001-03-31

product revenue	53,661,000	57,751,000	52,698,000	52,445,000	43,239,000	50,809,000	46,017,000	45,079,000	38,365,000	46,768,000	39,772,000	38,853,000	30,974,000	44,034,000	39,571,000	40,999,000	37,444,000	39,865,000	36,131,000	31,484,000	23,379,000	28,199,000	23,607,000	21,503,000	18,611,000	20,917,000	18,019,000	18,209,000	17,504,000	16,525,000	15,399,000	15,420,000	13,564,000	16,240,000	10,797,000	9,525,000	7,006,000	10,125,000	10,175,000										7,866,000	9,232,000	10,542,000	10,150,000	9,733,000	10,528,000	8,252,000	9,224,000	8,691,000	9,896,000	7,770,000	6,753,000	6,183,000	5,965,000	4,521,000	5,690,000	5,500,000	5,228,000	4,567,000	3,871,000	3,085,000	3,541,000	3,095,000	4,030,000	4,852,000	2,395,000	2,762,000	1,671,000	1,187,000	926,000	794,000	776,000	479,000
cost of product revenue	25,767,000	28,002,000	24,558,000	23,470,000	17,815,000	23,424,000	19,818,000	20,413,000	17,093,000	20,809,000	17,956,000	17,515,000	13,687,000	19,498,000	17,662,000	19,718,000	18,076,000	19,475,000	17,582,000	15,323,000	11,095,000	12,179,000	10,953,000	9,705,000	8,320,000	9,293,000	7,583,000	8,111,000	8,432,000	8,442,000	8,142,000	7,720,000	7,330,000	9,129,000	5,348,000	4,360,000	3,694,000	5,605,000	5,451,000										4,157,000	4,939,000	6,826,000	5,747,000	5,090,000	5,117,000	4,411,000	5,574,000	5,514,000	6,462,000	4,650,000	3,978,000	3,445,000	3,630,000	2,324,000	2,934,000	3,158,000	3,724,000	4,242,000	2,520,000	2,094,000	2,964,000	1,913,000	3,077,000	1,714,000	1,664,000	1,673,000	1,067,000	824,000	705,000	373,000	281,000	182,000
gross profit on product revenue	27,894,000	29,749,000	28,140,000	28,975,000	25,424,000	27,385,000	26,199,000	24,666,000	21,272,000	25,959,000	21,816,000	21,338,000	17,287,000	24,536,000	21,909,000	21,281,000	19,368,000	20,390,000	18,549,000	16,161,000	12,284,000	16,020,000	12,654,000	11,798,000	10,291,000	11,624,000	10,436,000	10,098,000	9,072,000	8,083,000	7,257,000	7,700,000	6,234,000	7,111,000	5,449,000	5,165,000	3,312,000	4,520,000	4,724,000										3,709,000	4,293,000	3,716,000	4,403,000	4,643,000
government contract revenue	6,232,000	6,828,000	7,539,000	7,684,000	5,614,000	5,942,000	4,639,000	5,440,000	5,030,000	6,574,000	7,479,000	8,875,000	7,502,000	7,287,000	6,772,000	6,632,000	5,576,000	10,223,000	5,970,000	6,279,000	6,187,000	5,391,000	5,584,000	5,324,000	6,030,000	5,571,000	4,827,000	4,266,000	4,461,000	3,713,000	3,928,000	4,047,000	3,455,000
operating expenses:
research and development	14,532,000	16,390,000	15,825,000	18,900,000	16,605,000	15,443,000	14,013,000	14,969,000	14,482,000	14,288,000	16,783,000	19,184,000	17,384,000	18,614,000	16,220,000	15,216,000	14,057,000	15,572,000	15,288,000	17,083,000	15,748,000	17,061,000	15,921,000	15,618,000	15,810,000	16,438,000	16,081,000	14,417,000	13,440,000	12,421,000	10,825,000	9,881,000	9,437,000	7,783,000	7,886,000	8,891,000	9,150,000	8,815,000	7,033,000	8,557,000	6,917,000	7,160,000	7,689,000	5,213,000	5,581,000	5,186,000	7,250,000	4,722,000	4,642,000	4,618,000	4,363,000	3,506,000	2,700,000	2,164,000	1,903,000	1,712,000	1,824,000	1,562,000	1,814,000	1,994,000	1,808,000	1,419,000	1,282,000	1,244,000	1,250,000	1,505,000	1,230,000	1,625,000	2,012,000	2,268,000	2,483,000	2,670,000	3,076,000	-5,129,000	6,881,000	6,757,000	6,448,000	7,438,000	7,030,000	8,357,000	6,682,000	6,578,000	6,626,000	5,881,000	5,049,000	5,073,000	5,190,000	8,720,000	8,668,000	13,400,000	14,752,000	14,695,000	14,881,000	14,484,000	11,921,000	12,194,000	12,086,000	11,318,000
selling, general and administrative	19,948,000	20,828,000	18,618,000	21,182,000	20,286,000	19,333,000	17,786,000	18,973,000	19,799,000	17,269,000	16,155,000	20,541,000	21,551,000	23,160,000	19,908,000	19,532,000	20,735,000	22,003,000	20,357,000	19,758,000	19,170,000	18,691,000	16,299,000	16,112,000	15,913,000	17,164,000	16,140,000	16,740,000	16,161,000	14,833,000	13,964,000	14,437,000	13,607,000	12,506,000	12,180,000	14,094,000	13,633,000	12,439,000	12,161,000	12,406,000	11,747,000	11,276,000	10,932,000	12,063,000	11,718,000	10,689,000	8,724,000	10,080,000	8,236,000	7,430,000	7,728,000	7,954,000	6,853,000	6,794,000	6,219,000	6,686,000	5,966,000	5,938,000	5,380,000	6,207,000	5,528,000	3,916,000	5,089,000	5,304,000	5,270,000	4,212,500	5,340,000	5,409,000	6,101,000	5,401,750	7,067,000	7,439,000	6,809,000	4,276,000	5,631,000	6,151,000	5,322,000	2,537,750	3,273,000	3,762,000	3,116,000
total operating expenses	34,480,000	37,218,000	34,443,000	40,082,000	36,891,000	34,776,000	31,799,000	33,942,000	34,281,000	31,557,000	34,538,000	41,853,000	38,935,000	41,774,000	36,128,000	34,748,000	34,792,000	37,575,000	35,645,000	36,841,000	34,918,000	35,752,000	32,220,000	31,730,000	31,723,000	33,602,000	32,221,000	31,157,000	29,601,000	27,254,000	24,789,000	24,318,000	23,044,000	20,340,000	20,116,000	23,036,000	22,833,000	21,455,000	19,244,000	21,014,000	18,714,000	18,487,000	18,671,000	17,327,000	17,349,000	15,926,000	16,024,000	14,853,000	12,928,000	12,099,000	12,141,000	11,511,000	9,603,000	9,009,000	8,172,000	8,449,000	7,840,000	7,550,000	7,245,000	8,252,000	7,386,000	7,581,000	6,371,000	6,548,000	6,520,000	6,662,000	6,585,000	7,163,000	8,825,000	7,825,000	9,550,000	10,109,000	9,885,000	-1,222,000	14,185,000	23,425,000	12,594,000	12,004,000	10,676,000	12,400,000	9,980,000	8,958,000	8,787,000	8,497,000	7,470,000	7,347,000	7,575,000	14,104,000	11,711,000	15,987,000	17,575,000	17,390,000	17,806,000	17,508,000	14,723,000	14,541,000	14,744,000	13,697,000
income from operations	-354,000	-641,000	1,236,000	-3,423,000	-5,853,000	-1,449,000	-961,000	-3,836,000	-7,979,000	976,000	-5,243,000	-11,640,000	-14,146,000	-9,951,000	-7,447,000	-6,835,000	-9,848,000	-6,962,000	-11,126,000	-14,401,000	-16,447,000	-14,341,000	-13,982,000	-14,608,000	-15,402,000	-16,407,000	-16,958,000	-16,793,000	-16,068,000	-15,458,000	-13,604,000	-12,571,000	-13,355,000	-10,851,000	-12,382,000	-16,204,000	-18,093,000	-15,104,000	-14,259,000	-16,739,000	-15,345,000	-14,993,000	-16,186,000	-15,525,000	-14,371,000	-12,929,000	-11,351,000	-11,004,000	-9,219,000	-7,806,000	-8,425,000	-7,108,000	-4,960,000	-3,598,000	-4,331,000	-4,799,000	-4,572,000	-3,589,000	-2,646,000	-5,477,000	-4,212,000	-4,750,000	-3,704,000	-3,547,000	-3,956,000	-4,912,000	-6,013,000	-5,477,000	-7,431,000	-7,163,000	-7,581,000	-9,156,000	-6,630,000	-5,874,000	-10,485,000	-18,911,000	-7,896,000	2,145,000	-2,702,000	-5,940,000	-2,983,000																	-12,253,000
yoy	-93.95%	-55.76%	-228.62%	-10.77%	-26.64%	-248.46%	-81.67%	-67.04%	-43.60%	-109.81%	-29.60%	70.30%	43.64%	42.93%	-33.07%	-52.54%	-40.12%	-51.45%	-20.43%	-1.42%	6.78%	-12.59%	-17.55%	-13.01%	-4.14%	6.14%	24.65%	33.59%	20.31%	42.46%	9.87%	-22.42%	-26.19%	-28.16%	-13.16%	-3.20%	17.91%	0.74%	-11.91%	7.82%	6.78%	15.96%	42.60%	41.09%	55.88%	65.63%	34.73%	54.81%	85.87%	116.95%	94.53%	48.11%	8.49%	0.25%	63.68%	-12.38%	8.55%	-24.44%	-28.56%	54.41%	6.47%	-3.30%	-38.40%	-35.24%	-46.76%	-31.43%	-20.68%	-40.18%	12.08%	21.94%	-27.70%	-51.58%	-16.03%	-373.85%	288.05%	218.37%	164.70%
qoq	-44.77%	-151.86%	-136.11%	-41.52%	303.93%	50.78%	-74.95%	-51.92%	-917.52%	-118.62%	-54.96%	-17.72%	42.16%	33.62%	8.95%	-30.60%	41.45%	-37.43%	-22.74%	-12.44%	14.69%	2.57%	-4.29%	-5.16%	-6.13%	-3.25%	0.98%	4.51%	3.95%	13.63%	8.22%	-5.87%	23.08%	-12.36%	-23.59%	-10.44%	19.79%	5.93%	-14.82%	9.08%	2.35%	-7.37%	4.26%	8.03%	11.15%	13.90%	3.15%	19.36%	18.10%	-7.35%	18.53%	43.31%	37.85%	-16.92%	-9.75%	4.97%	27.39%	35.64%	-51.69%	30.03%	-11.33%	28.24%	4.43%	-10.34%	-19.46%	-18.31%	9.79%	-26.30%	3.74%	-5.51%	-17.20%	38.10%	12.87%	-43.98%	-44.56%	139.50%	-468.11%	-179.39%	-54.51%	99.13%
operating margin %	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-180.94%	-201.06%	-155.27%	-201.19%	-175.82%	-186.83%	-192.76%	-109.54%	-127.94%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	-Infinity%
non-operating expense, net:
foreign exchange gain	150,000			-911,000	-287,000	543,000	-241,000	-77,000	145,000	5,500	166,000	49,000		-622,000	234,000	-104,000		-130,000	-164,000	118,000		253,000	490,000	273,000		-77,750	-254,000	105,000	-162,000	-65,000	8,000		108,000			-14,000				101,000				499,000	-1,113,000	-351,000	-941,000		21,000	335,000	409,000		-54,000	298,000	206,000	-748,000	330,000	100,000	-39,000	-258,000	697,000	-570,000	827,000	-975,000
interest expense	-1,872,000	-1,964,000	-2,119,000	-2,150,000	-2,110,000	-2,053,000	-2,260,000	-2,330,000	-2,234,000	-2,229,000	-2,364,000	-2,181,000	-1,612,000	-1,697,000	-1,406,000	-1,348,000	-1,380,000	-1,334,000	-1,279,000	-1,338,000	-972,000	-952,000	-930,000	-929,000	-935,000	-960,000	-1,031,000	-1,150,000	-2,924,000	-1,082,000	-1,053,000	-958,000	-915,000	-900,000	-1,090,000	-501,000	-531,000	-546,000	-586,000	-658,000	-655,000	-644,000	-505,000	-301,000	-255,000	77,000	-342,000	-141,000	-193,000	-241,000	-41,000	-107,000	-131,000	-141,000	-136,000	-135,000	-139,000	-117,000	-394,000	-220,000	-233,000	-231,000	-226,000
other income	519,000	589,000	976,000	845,000	606,000	508,000	604,000	412,000	452,000	606,000	233,000	539,000	387,000	-1,088,000	165,000	-30,000	-782,000	-624,000	205,000	337,000	456,000	751,000	351,000	460,000	151,000	301,000	336,000	337,000	422,000	460,000	513,000	444,000	331,000	142,000	104,000	3,512,000	106,000	847,000	114,000	113,000	66,000	35,000	7,000	27,000	2,000	-319,000	145,000	134,000	170,000	201,000	32,000	16,000	17,000	-6,000	-72,000	101,000	8,000				16,000	546,000	-8,000	-252,000	-1,066,000	-81,250	376,000	-735,000
total non-operating expense	-1,203,000	-1,424,000	-1,171,000	-2,216,000	-1,791,000	-1,002,000	-1,897,000	-1,995,000	-1,637,000	-2,293,000	-1,965,000	-1,593,000	-1,418,000	-3,407,000	-1,007,000	-1,482,000	-2,360,000	-2,088,000	-1,238,000	-883,000	-912,000	52,000	-89,000	-196,000	-1,007,000	-1,080,250	-949,000	-708,000	-2,664,000				-476,000				-470,000																-5,241,000				-4,262,000			-836,000	-798,000
income before income taxes	-1,557,000	-2,065,000	65,000	-5,639,000	-7,644,000	-2,451,000	-2,858,000	-5,831,000	-9,616,000	-1,317,000	-7,208,000	-13,233,000	-15,564,000	-13,358,000	-8,454,000	-8,317,000	-12,208,000	-9,050,000	-12,364,000	-15,284,000	-17,359,000	-14,289,000	-14,071,000	-14,804,000	-16,409,000	-16,841,000	-17,907,000	-17,501,000	-18,732,000	-16,145,000	-14,136,000	-13,223,000	-13,831,000	-11,560,000	-13,368,000	-13,207,000	-18,563,000	-14,705,000	-14,792,000	-17,183,000	-16,051,000	-16,506,000	-15,585,000	-18,007,000	-9,441,000	-20,077,000	-10,751,000	-7,545,000	-187,000	-5,807,000	-20,441,000	-6,670,000	-10,201,000
provision for income taxes	91,000	119,000	85,000	76,000	74,000	111,000	76,000	-56,000	74,000	72,000	78,000	98,000	77,000	267,000	67,000	78,000	76,000	71,000	73,000	77,000	98,000	92,000	68,000	67,000	57,000	82,000	60,000	61,000	60,000	60,000	56,000	59,000	54,000	-74,000	50,000	3,876,000	35,000	-1,204,000	-416,000	983,000	812,000	-1,750,000	95,000	-2,035,000	19,000	105,000	8,000	44,000	38,000	53,000	60,000	54,000	51,000																																													-100,000
net income	-1,648,000	-2,184,000	-20,000	-5,715,000	-7,718,000	-2,562,000	-2,934,000	-5,775,000	-9,690,000	-1,389,000	-7,286,000	-13,331,000	-15,641,000	-13,625,000	-8,521,000	-8,395,000	-12,284,000	-9,121,000	-12,437,000	-15,361,000	-17,457,000	-14,381,000	-14,139,000	-14,871,000	-16,466,000	-16,923,000	-17,967,000	-17,562,000	-18,792,000	-16,205,000	-14,192,000	-13,282,000	-13,885,000	-11,486,000	-13,418,000	-17,083,000	-18,598,000	-13,501,000	-14,376,000	-18,166,000	-16,863,000	-14,756,000	-15,680,000	-15,972,000	-9,460,000	-20,182,000	-10,759,000	-7,589,000	-225,000	-5,860,000	-20,501,000	-6,724,000	-10,252,000	-1,716,000	-3,460,000	-1,907,000	-8,834,000	-7,997,000	2,338,000	-6,313,000	-5,010,000	-2,630,000	-3,832,000	-5,427,000	-5,022,000	-4,889,000	-5,637,000	-6,212,000	-7,397,000	-5,978,000	-8,818,000	-9,093,000	-5,292,000	-11,430,000	-9,151,000	-17,915,000	-6,808,000	3,010,000	-1,787,000	-5,072,000	-930,000	-3,894,000	-1,666,000	-2,761,000	21,385,000	-5,352,000	-5,060,000	-11,547,000	-9,194,000	-14,208,000	-16,772,000	-17,159,000	-16,591,000	-11,284,000	-13,547,000	-12,726,000	-11,975,000	-11,165,000
yoy	-78.65%	-14.75%	-99.32%	-1.04%	-20.35%	84.45%	-59.73%	-56.68%	-38.05%	-89.81%	-14.49%	58.80%	27.33%	49.38%	-31.49%	-45.35%	-29.63%	-36.58%	-12.04%	3.30%	6.02%	-15.02%	-21.31%	-15.32%	-12.38%	4.43%	26.60%	32.22%	35.34%	41.08%	5.77%	-22.25%	-25.34%	-14.92%	-6.66%	-5.96%	10.29%	-8.51%	-8.32%	13.74%	78.26%	-26.89%	45.74%	110.46%	4104.44%	244.40%	-47.52%	12.86%	-97.81%	241.49%	492.51%	252.60%	16.05%	-78.54%	-247.99%	-69.79%	76.33%	204.07%	-161.01%	16.33%	-0.24%	-46.21%	-32.02%	-12.64%	-32.11%	-18.22%	-36.07%	-31.68%	39.78%	-47.70%	-3.64%	-49.24%	-22.27%	-479.73%	412.09%	253.21%	632.04%	-177.30%	7.26%	83.70%	-104.35%	-27.24%	-67.08%	-76.09%	-332.60%	-62.33%	-69.83%	-32.71%	-44.58%	25.91%	23.81%	34.83%	38.55%	1.07%
qoq	-24.54%	10820.00%	-99.65%	-25.95%	201.25%	-12.68%	-49.19%	-40.40%	597.62%	-80.94%	-45.35%	-14.77%	14.80%	59.90%	1.50%	-31.66%	34.68%	-26.66%	-19.04%	-12.01%	21.39%	1.71%	-4.92%	-9.69%	-2.70%	-5.81%	2.31%	-6.55%	15.96%	14.18%	6.85%	-4.34%	20.89%	-14.40%	-21.45%	-8.15%	37.75%	-6.09%	-20.86%	7.73%	14.28%	-5.89%	-1.83%	68.84%	-53.13%	87.58%	41.77%	3272.89%	-96.16%	-71.42%	204.89%	-34.41%	497.44%	-50.40%	81.44%	-78.41%	10.47%	-442.04%	-137.03%	26.01%	90.49%	-31.37%	-29.39%	8.06%	2.72%	-13.27%	-9.26%	-16.02%	23.74%	-32.21%	-3.02%	71.83%	-53.70%	24.90%	-48.92%	163.15%	-326.18%	-268.44%	-64.77%	445.38%	-76.12%	133.73%	-39.66%	-112.91%	-499.57%	5.77%	-56.18%	25.59%	-35.29%	-15.29%	-2.26%	3.42%	47.03%	-16.70%	6.45%	6.27%	7.25%
net income margin %	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-196.37%	-220.95%	-152.82%	-194.90%	-180.88%	-122.98%	-300.90%	-103.83%	-88.23%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%	-Infinity%
net loss attributable to noncontrolling interest	-8,000		-1,000	-8,000	-1,000	-41,000			-2,000	-61,000	-19,000	-56,000	-22,000	-1,000	-39,000	-6,000
net loss attributable to cerus corporation	-1,640,000	-2,184,000	-19,000	-5,707,000	-7,717,000	-2,521,000	-2,934,000	-5,775,000	-9,688,000	-1,328,000	-7,267,000	-13,275,000	-15,619,000	-13,624,000	-8,482,000	-8,389,000	-12,284,000	-9,119,000	-12,437,000
net income per share																																																													-0.11	-0.093	-0.1	-0.14	-0.13	-0.145	-0.16	-0.19	-0.23	-0.18	-0.27	-0.28	-0.16												0.96	-0.24	-0.23	-0.52	-0.42	-0.64	-0.97	-1.07	-1.05	-0.71	-0.86	-0.81	-0.8	-0.79
basic and diluted	-0.01	-0.01		-0.03	-0.04	-0.01	-0.02	-0.03	-0.05	-0.01	-0.04	-0.07	-0.09	-0.07	-0.05	-0.05	-0.07	-0.05	-0.07	-0.09	-0.1	-0.09	-0.08	-0.09	-0.1	-0.12	-0.13	-0.13
weighted-average shares outstanding:
basic and diluted	194,142	190,594	191,830	191,301	187,066	184,563	185,424	184,982	182,090	180,270	180,938	180,611	178,273	176,545	177,236	176,944	174,478	171,279	171,904	171,240	168,824	163,949	166,572	164,383	157,405	139,831	140,908	138,281																																							35,000	32,650
foreign exchange loss		-306,500	-28,000										-193,000				-198,000				-396,000				-223,000							-138,000		-14,750			-45,000	-19,250	-61,000		-117,000	-156,000	-10,000					-25,000				-157,000
restructuring											1,600,000	2,128,000																																																						-15,000	15,000	129,000	712,000																		396,000	2,465,000
weighted-average shares used for eps calculation
basic and diluted	194,142	190,594	191,830	191,301	187,066	184,563	185,424	184,982	182,090	180,270	180,938	180,611	178,273	176,545	177,236	176,944	174,478	171,279	171,904	171,240	168,824	163,949	166,572	164,383	157,405	139,831	140,908	138,281																																							35,000	32,650
net income per share																																																													-0.11	-0.093	-0.1	-0.14	-0.13	-0.145	-0.16	-0.19	-0.23	-0.18	-0.27	-0.28	-0.16												0.96	-0.24	-0.23	-0.52	-0.42	-0.64	-0.97	-1.07	-1.05	-0.71	-0.86	-0.81	-0.8	-0.79
basic																													-0.14	-0.12	-0.11	-0.1	-0.11	-0.1	-0.12	-0.16	-0.18	-0.13	-0.14	-0.18	-0.17	-0.15	-0.16	-0.17	-0.1	-0.27	-0.14	-0.1						-65	-60			-47.5	50																		-210	120	-60	-180	-40
diluted																													-0.14	-0.12	-0.11	-0.1	-0.11	-0.1	-0.12	-0.16	-0.18	-0.13	-0.14	-0.18	-0.17	-0.13	-0.17	-0.17	-0.17	-0.17	-0.16	-0.16	-0.12					-65	-80			-47.5	50																		-210	120	-60	-180	-40
weighted-average shares outstanding used for calculating net loss per share:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
non-operating income, net:
total non-operating income																														-687,000	-532,000	-652,000		385,250	-986,000	2,997,000		399,000	-533,000	-444,000	-706,000	-1,513,000	601,000	-2,482,000	4,930,000					1,999,000	-12,016,000	438,000		2,124,000	871,000	2,892,000		837,500	4,984,000			2,120,000	-128,000	-1,880,000
government contracts revenue																																		1,345,000	2,285,000	1,667,000	1,428,000	1,831,000	261,000
amortization of intangible assets																																		51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	51,000	50,000	50,000	51,000	51,000	50,000
gain from revaluation of warrant liability																																										-1,132,000	1,109,000	-2,707,000	6,296,000	-6,555,000	1,738,000	3,491,000	9,034,000									-3,336,000	5,439,000
revenue																																								9,251,000	7,632,000	9,656,000	8,045,000	8,830,000	7,692,000	6,707,250	10,362,000	8,601,000
yoy																																								4.77%	-0.78%	43.96%	-22.36%	2.66%
qoq																																								21.21%	-20.96%	20.02%	-8.89%	14.79%	14.68%	-35.27%	20.47%
cost of revenue																																								4,976,000	4,263,000	6,162,000	5,560,000	7,028,000	4,714,000	3,649,500	5,689,000	4,752,000
gross profit																																								4,275,000	3,369,000					3,057,750	4,673,000	3,849,000						2,689,750	3,841,000	3,650,000	3,268,000	3,961,000	4,599,000	2,775,000	3,174,000	2,831,000	2,667,000	3,001,000	2,564,000	1,750,000	572,000	1,686,000	1,394,000	662,000	1,969,000	953,000	3,255,000
yoy																																																						-32.09%	-16.48%	31.53%	2.96%	39.92%	72.44%	-7.53%	23.79%	61.77%	366.26%	78.00%	83.93%	164.35%	-70.95%	76.92%	-57.17%
qoq																																								26.89%						-34.57%	21.41%							-29.97%	5.23%	11.69%	-17.50%	-13.87%	65.73%	-12.57%	12.12%	6.15%	-11.13%	17.04%	46.51%	205.94%	-66.07%	20.95%	110.57%	-66.38%	106.61%	-70.72%
gross margin %	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	46.21%	44.14%	0%	0%	0%	0%	45.59%	45.10%	44.75%	NaN%	NaN%	NaN%	NaN%	NaN%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
gross profit on revenue																																										1,816,250	2,485,000	1,802,000	2,978,000
weighted-average shares outstanding used in the calculation of net loss per share:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
non-operating gain (expense), net:
total non-operating gain (expense)																																														3,272,750	600,000	3,459,000	9,032,000
revenue:
government grants and cooperative agreements revenue
revaluation of warrant liability																																																		1,704,000	-12,416,000	686,000		1,973,000	873,000	3,674,000					-1,278,000
net loss per common share:
basic																																																		-80	-290	-100	-170			-40	-170			-130														-265	-290	-560
diluted																																																		-80	-290	-100	-170			-100	-170			-130														-265	-290	-560
weighted-average common shares outstanding used for calculating net loss per common share:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
loss from revaluation of warrant liability																																																					-5,073,000				-4,461,000			-339,000
government grants and cooperative agreements																																																						22,750			91,000	527,000	1,479,000		436,000													-4,133,000	938,000	2,713,000		1,081,000	4,583,000	1,480,000		2,642,000	3,519,000	2,800,000	3,228,000	2,247,750	2,324,000	3,301,000	3,366,000	2,587,000	1,882,000	1,080,000	563,000	613,000	398,000	217,000	314,000	373,000
total revenue																																																						6,564,500	8,252,000	9,224,000	8,782,000	10,423,000	9,249,000	6,753,000	6,619,000	6,461,000	4,991,000	5,935,000	5,722,000	5,474,000	4,814,000	4,206,000	3,488,000	3,626,000	3,882,000	4,030,000	4,969,000	-1,868,000	3,700,000	4,514,000	4,698,000	14,149,000	7,974,000	6,460,000	6,997,000	5,610,000	6,880,000	5,480,000	6,401,000	2,738,000	3,539,000	3,766,000	3,647,000	2,868,000	2,003,000	1,269,000	730,000	5,649,000	503,000	517,000	1,559,000	1,444,000
net income per common share:
basic																													-0.14	-0.12	-0.11	-0.1	-0.11	-0.1	-0.12	-0.16	-0.18	-0.13	-0.14	-0.18	-0.17	-0.15	-0.16	-0.17	-0.1	-0.27	-0.14	-0.1						-65	-60			-47.5	50																		-210	120	-60	-180	-40
diluted																													-0.14	-0.12	-0.11	-0.1	-0.11	-0.1	-0.12	-0.16	-0.18	-0.13	-0.14	-0.18	-0.17	-0.13	-0.17	-0.17	-0.17	-0.17	-0.16	-0.16	-0.12					-65	-80			-47.5	50																		-210	120	-60	-180	-40
weighted-average common shares outstanding used for calculating net income per common share:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
acquisition related costs
non-operating income:
other expense																																																										-6,250	-22,000	-19,000
net loss per common share:
net income per share																																																													-0.11	-0.093	-0.1	-0.14	-0.13	-0.145	-0.16	-0.19	-0.23	-0.18	-0.27	-0.28	-0.16												0.96	-0.24	-0.23	-0.52	-0.42	-0.64	-0.97	-1.07	-1.05	-0.71	-0.86	-0.81	-0.8	-0.79
weighted-average common shares outstanding used for basic and diluted net loss per share:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
government grants and cooperative agreement																																																														234,000	470,000	245,000	222,000	246,250	247,000	335,000	403,000	226,000	787,000		117,000				3,511,000				2,701,000
warrant liability revaluation																																																														-584,000	-721,000	-653,000
per share information:
weighted-average common shares outstanding basic and diluted																																																															39,310	38,940
weighted-average common shares outstanding used for basic and per share information:
basic and diluted	194,142	190,594	191,830	191,301	187,066	184,563	185,424	184,982	182,090	180,270	180,938	180,611	178,273	176,545	177,236	176,944	174,478	171,279	171,904	171,240	168,824	163,949	166,572	164,383	157,405	139,831	140,908	138,281																																							35,000	32,650
weighted-average common shares outstanding used for basic and diluted per share information:
basic and diluted	194,142	190,594	191,830	191,301	187,066	184,563	185,424	184,982	182,090	180,270	180,938	180,611	178,273	176,545	177,236	176,944	174,478	171,279	171,904	171,240	168,824	163,949	166,572	164,383	157,405	139,831	140,908	138,281																																							35,000	32,650
interest income and other																																																																					34,000			63,000	1,338,000	648,000	1,334,000	996,000	1,088,000	865,000	915,000	868,000	2,053,000
impairment of long-term investment in related party																																																																												9,450,000
interest and other income																																																																						41,000	-1,237,000
loss from continuing operations																																																																						-5,800,750	-8,818,000	-9,093,000
discontinued operations:
loss from discontinued operations
loss from continuing operations per share – basic and diluted																																																																						-0.18	-0.27
loss from discontinued operations per share – basic and diluted
weighted-average common shares outstanding used for basic and per share information:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
loss from continuing operations per share –basic and diluted																																																																								-0.28
loss from discontinued operations per share –basic and diluted
net income from continuing operations																																																																									-5,292,000
net loss from discontinued operations
net loss from continuing operations per share – basic and diluted																																																																									-0.16
net loss from discontinued operations per share – basic and diluted
milestone and development funding																																																																										32,500		130,000		12,142,000	2,597,000	4,204,000	3,817,000
milestone and development revenue from related party
weighted-average common shares outstanding used for basic and diluted net income per share:
basic																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,068	96,864	95,728	93,411	74,767	75,194	72,899	72,088	67,569,000	69,791,000	69,727,000	59,730,000	54,515,000	54,875,000	54,418,000	53,088,000	48,050,000	47,710,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	22,350
diluted																													137,108	131,663	134,326	131,352	124,814	108,221	109,846	105,044	103,564	101,826	102,769	101,563	99,471	96,905	97,605	95,728	94,662	76,534	76,103	74,517	75,158	67,569,000	69,791,000	71,928,000	59,730,000	55,061,000	55,377,000	55,236,000	53,088,000	48,050,000	48,820,000	47,620,000	47,450	40,300			38,830	34,750			32,590	32,430	32,530	32,450	32,210	31,870	31,850	31,810	31,760	26,870	27,800	27,770	23,040	23,950
gain on loan settlement																																																																																					22,089,000
development funding																																																																																		2,204,750	3,292,000	2,594,000													1,245,000
product sales																																																																																		90,000	69,000	86,000	240,000					24,000	8,000	20,000
general and administrative																																																																																		2,380,000	2,161,000	2,616,000	2,421,000	2,274,000	1,989,000	2,919,000	3,043,000	2,587,000	2,823,000	2,695,000	2,925,000	3,024,000	2,802,000	2,347,000	2,658,000	2,379,000
interest income																																																																																		215,500	241,000	256,000	365,000								485,000	575,000	673,000	1,298,000	1,210,000	1,188,000
net income (loss) per share - basic																																																																																		0.19	-0.07	-0.12
net income (loss) per share - diluted																																																																																		0.18	-0.07	-0.12
shares used in computing net income per share - basic																																																																																		5,579.25	22,373	22,321	22,257
shares used in computing net income per share - diluted																																																																																		5,923.5	22,373	22,321	23,285
development funding, related parties																																																																																					2,027,000	228,250	420,000								2,000	69,000
development funding, other																																																																																					906,000	262,000	795,000	164,000	89,000	257,000	113,000	169,000	167,000	36,000	103,000	231,000
interest expense and other income
shares used in computing net loss per share - basic and diluted																																																																																						5,530.25	22,166	22,113	22,084	22,031	17,317	15,964	15,874	15,782	15,751	15,711		14,097
development funding, related party																																																																																								301,000	192,000
milestone and development funding, related parties																																																																																														5,000,000
interest income (expense)
income before provision for income taxes																																																																																																		-11,065,000
shares used in computing net loss per share
- basic and diluted																																																																																																	14,887
milestones and development funding																																																																																																		1,071,000

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-09-30	2003-06-30	2003-03-31	2002-09-30	2002-06-30	2002-03-31	2001-09-30	2001-06-30	2001-03-31

assets
current assets:
cash and cash equivalents	27,850,000	19,961,000	15,670,000	15,991,000	19,476,000	20,266,000	21,575,000	12,402,000	20,527,000	11,647,000	17,389,000	20,635,000	27,604,000	35,585,000	28,875,000	32,309,000	38,372,000	48,759,000	78,460,000	59,030,000	57,607,000	36,594,000	28,950,000	34,900,000	33,679,000	34,986,000	24,425,000	23,543,000	29,002,000	28,859,000	22,327,000	14,305,000	14,877,000	13,683,000	16,985,000	20,278,000	10,930,000	22,560,000	12,880,000	7,704,000	20,791,000	71,018,000	50,795,000	35,059,000	17,934,000	22,781,000	22,343,000	28,562,000	23,992,000	29,485,000	24,355,000	58,201,000	69,163,000	26,696,000	26,661,000	26,667,000	31,449,000	25,497,000	14,761,000	17,167,000	23,599,000	28,948,000	11,884,000	14,139,000	16,813,000	17,287,000	19,466,000	7,790,000	6,983,000	10,303,000	15,306,000	22,405,000	21,743,000	19,625,000	37,986,000	33,287,000	39,192,000	46,287,000	42,566,000	56,696,000	52,787,000	5,780,000	5,405,000	4,933,000	4,836,000	39,169,000	7,614,000	7,900,000	25,743,000	52,878,000	92,828,000	55,347,000	42,128,000	26,491,000	47,956,000	99,301,000	138,368,000	69,212,000
short-term investments	52,575,000	62,918,000	62,842,000	62,034,000	61,443,000	60,186,000	53,990,000	58,792,000	51,651,000	54,205,000	61,617,000	63,868,000	67,076,000	66,569,000	74,952,000	74,738,000	70,185,000	80,600,000	41,501,000	63,811,000	74,118,000	97,000,000	106,174,000	101,570,000	99,426,000	50,732,000	60,686,000	72,659,000	71,426,000	88,718,000	96,669,000	97,605,000	90,988,000	47,013,000	42,645,000	30,628,000	39,117,000	45,116,000	63,396,000	76,350,000	70,513,000	25,698,000	48,968,000	75,854,000	93,959,000	28,513,000	25,231,000	21,134,000	24,263,000	28,191,000							87,000	287,000	457,000	613,000	758,000	1,061,000	1,325,000	1,725,000	2,173,000	2,644,000	3,194,000	5,072,000	8,436,000	12,275,000	14,185,000	16,564,000	24,971,000	37,225,000	31,049,000	41,148,000	40,422,000	47,129,000	27,025,000	19,428,000	30,042,000	40,025,000	43,835,000	47,242,000	51,022,000	56,165,000	81,973,000	86,917,000	73,703,000	70,247,000	42,956,000	41,059,000	39,667,000	66,783,000	59,540,000	38,602,000	8,933,000	10,902,000
accounts receivable	29,322,000	30,374,000	29,772,000	31,394,000	26,344,000	29,777,000	24,361,000	23,740,000	22,535,000	35,500,000	24,546,000	22,175,000	25,242,000	34,426,000	28,151,000	26,837,000	25,645,000	25,129,000	22,439,000	22,865,000	18,253,000	21,166,000	16,236,000	17,624,000	18,165,000	16,882,000	14,502,000	13,432,000	13,756,000	8,752,000	10,476,000	11,388,000	10,489,000	12,415,000	10,476,000	7,932,000	5,583,000	6,868,000	7,441,000	5,149,000	4,086,000	5,794,000	5,646,000	5,425,000	5,153,000	5,493,000	7,366,000	4,478,000	4,943,000	6,125,000	7,025,000	5,868,000	4,733,000	4,444,000	3,950,000	3,725,000	5,022,000	6,096,000	4,783,000	4,420,000	4,800,000	4,792,000	3,512,000	3,467,000	3,639,000	3,625,000	6,124,000	6,133,000	6,346,000	7,152,000	7,078,000	7,337,000	7,633,000	7,772,000	6,876,000	8,393,000	9,304,000	5,279,000
current inventories	61,123,000	56,101,000	53,139,000	54,529,000	48,161,000	38,150,000	36,538,000	36,290,000	39,862,000	39,868,000	42,661,000	40,608,000	36,614,000	29,003,000	28,329,000	27,758,000	28,521,000	26,793,000	29,420,000
prepaid and other current assets	4,471,000	5,030,000	5,704,000	4,586,000	6,091,000	3,643,000	4,148,000	3,806,000	3,594,000	3,221,000	4,723,000	3,650,000	5,680,000	4,561,000	4,424,000	3,030,000	10,089,000	5,821,000	6,232,000	8,629,000	7,009,000	5,417,000	6,479,000	6,452,000	5,365,000	6,018,000	5,798,000	8,756,000	4,958,000	7,034,000																													1,082,000	864,000	1,190,000	997,000			1,049,000	1,096,000			1,350,000	1,204,000	1,124,000	1,377,000	1,515,000	2,218,000	1,439,000	1,285,000	1,576,000	2,215,000
total current assets	175,341,000	174,384,000	167,127,000	168,534,000	161,515,000	152,022,000	140,612,000	135,030,000	138,169,000	144,441,000	150,936,000	150,936,000	162,216,000	170,144,000	164,731,000	164,672,000	172,812,000	187,102,000	178,052,000	185,590,000	181,272,000	183,431,000	177,299,000	178,971,000	178,319,000	128,108,000	126,317,000	135,837,000	134,920,000	146,902,000	150,154,000	141,198,000	133,776,000	89,898,000	88,434,000	74,307,000	75,720,000	94,105,000	108,029,000	112,212,000	119,437,000	130,439,000	128,423,000	144,471,000	136,419,000	74,885,000	72,652,000	70,320,000	67,079,000	78,154,000	74,502,000	77,770,000	87,440,000	43,996,000	43,536,000	40,789,000	46,598,000	39,739,000	30,674,000	33,032,000	39,473,000	41,755,000	25,300,000	26,901,000	30,516,000	32,359,000	38,315,000	29,858,000	34,220,000	42,043,000	48,001,000	59,674,000	65,385,000	73,902,000	81,293,000	88,203,000	93,071,000	102,743,000	81,051,000	83,364,000	91,962,000	51,005,000	54,477,000	56,635,000	60,438,000	99,871,000	94,205,000	100,910,000	106,788,000	127,830,000	140,077,000	100,191,000	83,979,000	101,054,000	110,475,000	138,920,000	148,505,000	81,452,000
non-current assets:
property and equipment	9,248,000	9,204,000	6,583,000	6,891,000	7,047,000	7,154,000	7,437,000	7,781,000	8,099,000	8,640,000	9,252,000	10,254,000	10,831,000	10,969,000	10,647,000	11,201,000	11,659,000	12,208,000	12,684,000	12,811,000	13,283,000	13,867,000	14,261,000	14,534,000	14,654,000	14,898,000	15,218,000	15,345,000	16,089,000	8,130,000	3,124,000	2,157,000	1,969,000	2,119,000	2,342,000	2,673,000	2,842,000	2,985,000	3,206,000	3,216,000	3,380,000	3,549,000	3,712,000	3,816,000	3,797,000	3,781,000	3,882,000	3,615,000	3,166,000	2,189,000	1,848,000	1,641,000	1,595,000	1,698,000	1,801,000	1,866,000	1,917,000	2,032,000	2,045,000	2,141,000	2,274,000	2,390,000	2,552,000	1,691,000	1,116,000	1,217,000	1,352,000	1,465,000	1,712,000	1,844,000	1,561,000	1,718,000	1,695,000	1,322,000	1,397,000	1,450,000	1,550,000	1,627,000
operating lease right-of-use assets	9,450,000	10,124,000	8,082,000	8,665,000	9,101,000	8,384,000	8,936,000	9,581,000	10,224,000	10,713,000	11,029,000	12,268,000	12,313,000	12,512,000	12,890,000	13,259,000	13,665,000	12,971,000	12,409,000	12,477,000	12,801,000	13,122,000	13,470,000	13,768,000	14,080,000	14,122,000	14,110,000	14,417,000	15,631,000
goodwill	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000	1,316,000
restricted cash	631,000	639,000	1,139,000	1,140,000	1,109,000	1,095,000	1,634,000	1,708,000	1,708,000	1,712,000	1,770,000	1,793,000	1,785,000	1,773,000	1,998,000	2,014,000	2,003,000	2,285,000	2,278,000	2,256,000	2,200,000	2,309,000	2,522,000	2,460,000	2,439,000	2,435,000	2,672,000	2,677,000	2,725,000	2,728,000	2,729,000	2,729,000	2,812,000	247,000	256,000	248,000	262,000	184,000	578,000	575,000	574,000	612,000	623,000	622,000	461,000	508,000	301,000	307,000	308,000	308,000	306,000	304,000	302,000	304,000	302,000	301,000	305,000	303,000	306,000	312,000	310,000	305,000	331,000	339,000	326,000	332,000	334,000	315,000	307,000	315,000
non-current inventories	15,723,000	15,143,000	15,010,000	14,349,000	15,164,000	14,145,000	14,811,000	16,801,000	17,913,000	19,501,000	21,287,000
other assets	11,199,000	11,049,000	15,928,000	12,176,000	11,524,000	16,801,000	14,793,000	13,279,000	11,707,000	11,425,000	10,254,000	22,293,000	20,875,000	21,378,000	23,821,000	23,994,000	20,451,000	21,617,000	12,207,000	8,773,000	9,710,000	7,370,000	4,486,000	4,414,000	4,473,000	4,524,000	4,622,000	4,802,000	4,961,000	4,050,000	3,949,000	4,011,000	4,062,000	4,128,000	4,151,000	4,304,000	4,113,000	4,148,000	2,207,000	2,293,000	2,341,000	2,614,000	123,000	140,000	140,000	144,000	51,000	51,000	64,000	70,000	72,000	72,000	58,000	59,000	101,000	144,000	186,000	229,000	413,000	450,000	408,000	451,000	494,000	961,000	539,000	583,000	686,000	720,000	761,000	808,000	848,000	835,000	820,000	1,111,000	508,000	437,000	368,000	272,000	267,000	264,000	269,000	245,000	1,260,000	1,260,000	1,260,000	85,000	86,000	117,000	131,000	151,000	154,000	156,000	153,000	218,000	214,000	162,000	137,000	127,000
total assets	222,908,000	221,859,000	215,185,000	213,071,000	206,776,000	200,917,000	189,539,000	185,496,000	189,136,000	197,748,000	205,844,000	198,860,000	209,336,000	218,092,000	215,403,000	216,456,000	221,906,000	237,499,000	218,946,000	223,223,000	220,582,000	221,415,000	213,354,000	215,494,000	215,363,000	165,535,000	164,438,000	174,627,000	175,926,000	163,460,000	161,657,000	151,846,000	144,421,000	98,244,000	97,086,000	83,485,000	84,941,000	103,476,000	116,125,000	120,451,000	127,938,000	139,470,000	135,188,000	151,406,000	143,225,000	81,776,000	79,395,000	76,852,000	73,227,000	83,381,000	79,439,000	82,548,000	92,207,000	48,919,000	48,653,000	46,063,000	52,020,000	45,367,000	36,552,000	39,100,000	45,680,000	48,167,000	32,160,000	29,892,000	32,497,000	34,491,000	43,027,000	34,561,000	39,164,000	47,339,000	52,398,000	64,210,000	70,020,000	78,209,000	85,030,000	91,815,000	106,164,000	115,817,000	89,010,000	91,362,000	99,953,000	58,660,000	56,802,000	58,785,000	62,578,000	102,078,000	96,303,000	102,210,000	108,786,000	131,369,000	144,323,000	105,185,000	90,296,000	107,546,000	116,074,000	141,799,000	151,546,000	84,485,000
liabilities and stockholders’ equity
current liabilities:
accounts payable	31,789,000	28,008,000	25,468,000	30,518,000	27,677,000	21,695,000	15,864,000	16,739,000	16,616,000	23,842,000	38,519,000	37,489,000	36,436,000	33,002,000	29,815,000	29,355,000	31,474,000	35,608,000	26,187,000	30,891,000	22,538,000	24,213,000	19,244,000	18,831,000	20,185,000	22,185,000	19,964,000	21,058,000	20,912,000	18,595,000	14,333,000	11,307,000	11,231,000	10,974,000	12,501,000	9,564,000	8,789,000	8,587,000	6,859,000	7,190,000	6,238,000	5,217,000	6,813,000	5,765,000	10,510,000	9,882,000	4,115,000	3,169,000	3,493,000	5,674,000	4,076,000	5,035,000	3,887,000	7,186,000	5,700,000	3,508,000	4,150,000	4,680,000	3,780,000	4,682,000	5,231,000	3,230,000	3,076,000	3,513,000	2,898,000	4,423,000	8,096,000	6,946,000	6,531,000	7,963,000	6,398,000	6,213,000	7,631,000	10,107,000	9,369,000	6,056,000	3,194,000	6,665,000	2,067,000	1,211,000	1,763,000	2,092,000	1,700,000	1,309,000	1,383,000	1,280,000	918,000	1,486,000	1,124,000	2,637,000	1,719,000	1,991,000	2,687,000	3,655,000	3,432,000	2,895,000	3,059,000	3,457,000
accrued liabilities	18,332,000	25,271,000	21,822,000	20,900,000	16,935,000	18,943,000	15,879,000	15,048,000	16,154,000	19,225,000	19,620,000	17,510,000	19,287,000	25,203,000	20,059,000	18,275,000	16,948,000	25,673,000	26,184,000	23,207,000	19,746,000	24,753,000	19,545,000	16,865,000	17,198,000	20,951,000	18,449,000	16,654,000	18,397,000	19,800,000	16,764,000	12,508,000	10,357,000	11,712,000	10,681,000	9,787,000	9,492,000	11,218,000	10,170,000	9,439,000	9,221,000	9,853,000	8,108,000	6,914,000	7,104,000	8,444,000	12,547,000	10,619,000	8,838,000	9,813,000	12,060,000	8,748,000	8,149,000	7,619,000	8,087,000	6,575,000	7,497,000	5,825,000	5,687,000	5,334,000	5,353,000	6,003,000	5,052,000	4,147,000	3,564,000	5,286,000	5,641,000	4,864,000	4,067,000	4,490,000	6,078,000	9,895,000	5,842,000	6,679,000	6,422,000	8,057,000	7,655,000	7,479,000	8,062,000	6,604,000	6,425,000
debt – current	52,397,000	43,343,000	36,249,000	28,125,000	20,097,000	19,297,000	18,521,000	18,782,000	20,120,000	20,000,000	18,779,000	16,542,000	18,000,000	56,159,000	42,380,000	28,680,000	15,011,000	14,697,000	9,986,000	9,329,000	9,938,000	8,516,000	4,982,000	4,950,000	4,813,000	5,017,000					5,714,000	3,572,000	1,429,000
operating lease liabilities – current	3,144,000	2,905,000	2,613,000	2,604,000	2,532,000	2,275,000	2,260,000	2,219,000	2,188,000	2,452,000	2,268,000	2,176,000	2,157,000	2,105,000	2,011,000	1,994,000	1,968,000	1,905,000	1,616,000	1,517,000	1,486,000	1,915,000	1,857,000	1,793,000	1,751,000	1,613,000	1,592,000	1,711,000	1,560,000
deferred revenue	1,721,000	1,274,000	2,281,000	2,211,000	2,449,000	1,398,000	1,821,000	1,096,000	2,167,000	2,002,000																																					560,000	266,000	279,000	181,000	111,000	153,000	174,000	77,000	716,000	136,000	197,000	111,000	74,000	123,000	161,000	248,000	233,000	212,000	375,000	345,000	303,000	659,000	410,000	445,000	85,000	60,000	289,000	1,504,000	39,000	32,000	126,000		2,054,000	4,107,000	7,572,000	11,135,000	6,630,000	8,549,000	10,469,000	13,217,000	3,690,000	1,584,000	641,000	611,000	647,000	682,000	754,000	789,000	825,000	1,166,000	937,000	964,000
total current liabilities	107,383,000	100,801,000	88,433,000	84,358,000	69,690,000	63,608,000	54,345,000	53,884,000	57,245,000	67,521,000	80,122,000	75,078,000	77,573,000	117,058,000	95,019,000	79,279,000	66,659,000	78,556,000	64,717,000	65,815,000	54,764,000	59,974,000	46,189,000	43,145,000	45,089,000	50,336,000	45,559,000	50,782,000	47,594,000	52,678,000	43,202,000	28,063,000	23,656,000	23,131,000	23,868,000	25,297,000	26,444,000	26,888,000	22,890,000	25,744,000	22,818,000	21,895,000	19,918,000	22,224,000	22,764,000	29,187,000	21,153,000	21,707,000	27,234,000	39,424,000	42,591,000	26,383,000	27,656,000	25,613,000	27,298,000	22,660,000	27,383,000	21,114,000	14,184,000	22,108,000	22,309,000	19,703,000	14,708,000	13,030,000	10,936,000	12,913,000	17,057,000	12,830,000	11,660,000	12,898,000	12,570,000	16,185,000	13,786,000	18,320,000	15,862,000	14,193,000	11,138,000	14,814,000	15,803,000	17,195,000	21,612,000	23,317,000	13,298,000	13,805,000	15,155,000	76,089,000	69,304,000	70,227,000	65,322,000	68,675,000	14,837,000	14,587,000	18,351,000	19,360,000	16,880,000	17,133,000	14,917,000	12,736,000
non-current liabilities:
debt – non-current	32,434,000	40,545,000	48,655,000	56,766,000	64,876,000	64,862,000	64,847,000	64,840,000	64,826,000	59,796,000	59,789,000	54,838,000	54,827,000	13,644,000	27,357,000	41,065,000	54,769,000	54,724,000	54,675,000	54,682,000	54,616,000	39,588,000	39,545,000	39,500,000	39,458,000	39,414,000	39,371,000	39,327,000	39,433,000		24,138,000
operating lease liabilities – non-current	9,383,000	10,153,000	10,669,000	11,403,000	11,941,000	11,663,000	12,270,000	12,851,000	13,469,000	13,751,000	14,083,000	14,454,000	14,960,000	15,329,000	15,703,000	16,221,000	16,787,000	16,260,000	16,079,000	16,319,000	16,697,000	16,873,000	17,263,000	17,611,000	18,005,000	18,406,000	18,458,000	18,722,000	19,311,000
other non-current liabilities	5,422,000	5,395,000	5,224,000	4,374,000	4,027,000	3,888,000	3,796,000	3,620,000	3,434,000	3,236,000	2,827,000	2,800,000	2,414,000	3,499,000	3,251,000	3,130,000	3,280,000	2,342,000	2,400,000	2,170,000	1,870,000	1,174,000	1,122,000	713,000	403,000	327,000	242,000	164,000	88,000	4,250,000	2,516,000	1,329,000	784,000	609,000	632,000	1,632,000	1,622,000	1,440,000	1,396,000	1,356,000	1,314,000	1,263,000	1,215,000	1,160,000	1,116,000	1,081,000	998,000	987,000	1,031,000	1,073,000	1,120,000	1,145,000	1,209,000	1,241,000	1,132,000	1,167,000	1,203,000	1,243,000	1,290,000	1,588,000	1,595,000	1,595,000	1,545,000	737,000	62,000		130,000	138,000	142,000		224,000	213,000	226,000
total liabilities	154,622,000	156,894,000	152,981,000	156,901,000	150,534,000	144,021,000	135,258,000	135,195,000	138,974,000	144,304,000	156,821,000	147,170,000	149,774,000	149,530,000	141,330,000	139,695,000	141,495,000	151,882,000	137,871,000	138,986,000	127,947,000	117,609,000	104,119,000	100,969,000	102,955,000	108,483,000	103,630,000	108,995,000	106,426,000	78,941,000	69,856,000	61,402,000	58,823,000	59,304,000	59,903,000	44,194,000	43,454,000	45,689,000	43,812,000	45,810,000	44,404,000	44,705,000	39,667,000	40,877,000	33,288,000	40,255,000	32,119,000	32,644,000	28,360,000	40,586,000	43,793,000	27,603,000	31,419,000	29,812,000	31,737,000	27,544,000	32,712,000	27,054,000	20,384,000	25,855,000	26,561,000	24,435,000	19,852,000	17,814,000	15,509,000	13,043,000	17,205,000	12,968,000	11,802,000	13,061,000	12,794,000	16,398,000	14,012,000	18,322,000	15,868,000	14,210,000	11,165,000	14,846,000	15,844,000	17,260,000	21,732,000	23,385,000
commitments and contingencies
stockholders’ equity:
common stock	200,000		192,000	191,000	191,000		185,000	185,000	185,000		181,000	181,000	180,000		177,000	177,000	177,000		172,000	172,000	168,000		167,000	166,000	164,000		142,000	140,000	138,000		136,000	133,000	131,000		112,000	109,000	103,000		103,000	102,000	101,000		97,000	97,000	95,000	80,000	77,000	74,000	72,000	72,000	70,000	70,000	70,000	56,000	55,000	55,000	54,000	51,000	48,000	48,000	48,000		40,000	39,000	39,000		38,000	33,000	33,000		33,000	32,000	32,000		32,000	32,000	32,000		28,000	28,000	28,000
additional paid-in capital	1,150,471,000	1,145,343,000	1,140,416,000	1,134,462,000	1,128,812,000	1,121,887,000	1,116,415,000	1,110,264,000	1,104,605,000	1,098,353,000	1,093,494,000	1,089,083,000	1,083,433,000	1,077,341,000	1,069,629,000	1,062,760,000	1,057,497,000	1,048,936,000	1,034,945,000	1,026,534,000	1,019,436,000	1,012,932,000	1,003,748,000	994,682,000	978,944,000	906,905,000	893,715,000	880,622,000	867,091,000	863,531,000	854,653,000	839,198,000	821,081,000	760,225,000	746,916,000	735,600,000	720,843,000	718,299,000	716,189,000	704,402,000	694,741,000	685,189,000	673,653,000	670,327,000	661,258,000	583,416,000	568,972,000	555,131,000	548,202,000	545,905,000	532,938,000	531,703,000	530,822,000	478,903,000	474,997,000	473,140,000	462,527,000	452,701,000	442,561,000	441,976,000	441,515,000	441,034,000	426,975,000	422,890,000	422,412,000	421,897,000	421,381,000	411,533,000	411,062,000	410,444,000	409,883,000	409,254,000	408,350,000	407,010,000	405,084,000	404,262,000	403,701,000	402,888,000	378,088,000	377,309,000	376,432,000	332,694,000				332,002,000
accumulated other comprehensive loss	-323,000	-156,000	-174,000	-273,000	-266,000	-400,000	-104,000	-867,000	-1,122,000	-1,274,000	-2,225,000	-2,433,000	-2,241,000	-2,787,000	-3,189,000	-2,153,000	-1,635,000												-70,000	-281,000	-326,000	-417,000	-426,000												-12,000						-33,000																								-154,000	-40,000		-23,000	-14,000	-87,000		-295,000
accumulated deficit	-1,082,795,000	-1,081,155,000	-1,078,971,000	-1,078,952,000	-1,073,245,000	-1,065,528,000	-1,063,007,000	-1,060,073,000	-1,054,298,000	-1,044,610,000	-1,043,282,000	-1,036,015,000	-1,022,740,000	-1,007,121,000	-993,497,000	-985,015,000	-976,626,000	-964,342,000	-955,223,000	-942,786,000	-927,425,000	-909,968,000	-895,587,000	-881,448,000	-866,577,000	-850,111,000	-833,188,000	-815,221,000	-797,659,000	-778,867,000	-762,662,000	-748,470,000	-735,188,000	-721,303,000	-709,817,000	-696,399,000	-679,316,000	-660,718,000	-647,217,000	-632,841,000	-614,675,000	-597,812,000	-583,056,000	-567,376,000	-551,404,000	-541,944,000	-521,762,000	-511,003,000	-503,414,000	-503,189,000	-497,329,000	-476,828,000	-470,104,000	-459,852,000	-458,136,000	-454,676,000	-452,769,000	-443,935,000	-435,938,000	-438,276,000	-431,963,000	-426,953,000	-424,323,000	-420,491,000	-415,064,000	-410,042,000	-405,153,000	-399,516,000	-393,304,000	-385,907,000	-379,929,000	-371,111,000	-362,018,000	-356,726,000	-345,296,000	-336,145,000	-318,230,000	-311,422,000	-314,432,000	-312,644,000	-307,573,000	-306,643,000
total cerus corporation stockholders’ equity	67,553,000	64,224,000	61,463,000	55,428,000	55,492,000	56,145,000	53,489,000
noncontrolling interest	733,000	741,000	741,000	742,000	750,000	751,000	792,000	792,000	792,000	794,000	855,000	874,000	930,000	952,000	953,000	992,000	998,000	998,000	1,000,000
total liabilities and stockholders’ equity	222,908,000	221,859,000	215,185,000	213,071,000	206,776,000	200,917,000	189,539,000																																		127,938,000	139,470,000	135,188,000	151,406,000	143,225,000	81,776,000	79,395,000	76,852,000	73,227,000	83,381,000	79,439,000	82,548,000	92,207,000	48,919,000	48,653,000	46,063,000	52,020,000	45,367,000	36,552,000	39,100,000	45,680,000	48,167,000	32,160,000	29,892,000	32,497,000	34,491,000	43,027,000	34,561,000	39,164,000	47,339,000	52,398,000	64,210,000	70,020,000	78,209,000	85,030,000	91,815,000	106,164,000	115,817,000	89,010,000	91,362,000	99,953,000	58,660,000	56,802,000	58,785,000	62,578,000	102,078,000	96,303,000	102,210,000	108,786,000	131,369,000	144,323,000	105,185,000	90,296,000	107,546,000	116,074,000	141,799,000	151,546,000	84,485,000
preferred stock, 0.001 par value...
common stock, 0.001 par value...		192,000				186,000				181,000				177,000				174,000				168,000				144,000				136,000				115,000				103,000				99,000																				47,000				39,000				33,000				32,000				32,000				23,000				22,000
liabilities and stockholders' equity
stockholders' equity:
total cerus corporation stockholders' equity								49,509,000	49,370,000	52,650,000	48,168,000	50,816,000	58,632,000	67,610,000	73,120,000	75,769,000	79,413,000	84,619,000	80,075,000
total liabilities and stockholders' equity								185,496,000	189,136,000	197,748,000	205,844,000	198,860,000	209,336,000	218,092,000	215,403,000	216,456,000	221,906,000	237,499,000	218,946,000	223,223,000	220,582,000	221,415,000	213,354,000	215,494,000	215,363,000	165,535,000	164,438,000	174,627,000	175,926,000	163,460,000	161,657,000	151,846,000	144,421,000	98,244,000	97,086,000	83,485,000	84,941,000	103,476,000	116,125,000	120,451,000
deferred product revenue											936,000	1,361,000	1,693,000	589,000	754,000	975,000	1,258,000	673,000	744,000	871,000	1,056,000	577,000	561,000	706,000
accumulated other comprehensive income																		-149,000	181,000	317,000	456,000	674,000	907,000	1,125,000	-123,000	114,000	139,000	91,000						-97,000	-28,000	-19,000	-143,000	103,000	3,238,000	2,978,000	3,367,000	7,289,000	4,827,000	7,481,000		-31,000	-11,000	6,000	7,000	7,000									1,000	1,000	23,000	108,000	120,000	144,000	105,000	58,000	60,000	47,000	75,000	212,000	121,000	141,000	148,000	75,000
inventories																				31,255,000	24,285,000	23,254,000	19,460,000	18,425,000	21,684,000	19,490,000	20,906,000	17,447,000	15,778,000	13,539,000	13,322,000	12,930,000	13,165,000	14,457,000	14,250,000	12,213,000	12,919,000	12,531,000	12,202,000	12,111,000	11,255,000	10,812,000	12,842,000	13,681,000	16,109,000	14,956,000	13,503,000	13,377,000	11,307,000	13,063,000	12,686,000	12,762,000	11,756,000	10,180,000	9,682,000	9,373,000	8,903,000	6,444,000	9,591,000	9,968,000	9,126,000	5,957,000	7,334,000	6,267,000	6,842,000	7,707,000	8,354,000	9,755,000	11,105,000	11,109,000	10,308,000	11,991,000	9,523,000	7,062,000	3,943,000	4,090,000	2,577,000	1,833,000	1,836,000	1,896,000
total stockholders' equity																				84,237,000	92,635,000	103,806,000	109,235,000	114,525,000	112,408,000	57,052,000	60,808,000	65,632,000	69,500,000	84,519,000	91,801,000	90,444,000	85,598,000	38,940,000	37,183,000	39,291,000	41,487,000	57,787,000	72,313,000	74,641,000
intangible assets																								31,000	82,000	132,000	183,000	233,000	284,000	334,000	385,000	435,000	486,000	536,000	587,000	637,000	688,000	738,000	789,000	839,000	890,000	940,000	991,000	1,041,000	1,092,000	1,142,000	1,193,000	1,243,000	1,294,000	1,344,000	1,395,000	1,445,000	1,496,000	1,546,000	1,597,000	1,647,000	1,698,000	1,748,000	1,798,000	1,849,000			3,483,000
deferred product revenue – current																									1,142,000	570,000	561,000	665,000	763,000		533,000	676,000	639,000
manufacturing and development obligations																												6,198,000	5,962,000
debt – revolving loan																											4,993,000	4,496,000
debt – term loan
debt - current																														7,857,000						5,548,000	7,693,000	6,934,000	4,969,000	6,127,000			1,449,000		591,000				3,268,000		3,638,000	2,157,000	4,470,000		4,919,000		3,099,000
manufacturing and development obligations – current																														5,928,000	5,858,000
deferred product revenue - current																														498,000				445,000	686,000	398,000	470,000	149,000	892,000
debt - non-current																														22,013,000		26,262,000	28,387,000	29,798,000	29,780,000	11,914,000	10,464,000	12,441,000	14,382,000	13,726,000			18,407,000		9,292,000		9,860,000						2,485,000		3,307,000		4,126,000
manufacturing and development obligations - non-current																																		5,766,000	5,623,000	5,351,000	4,924,000	4,770,000	5,004,000	4,844,000
other current assets																															7,360,000	4,970,000	4,257,000	1,109,000	4,078,000	3,256,000	3,461,000	1,804,000	5,457,000	5,345,000	6,333,000	4,788,000	953,000	1,411,000	1,933,000	1,932,000	2,429,000	1,416,000	913,000	442,000	394,000	200,000	418,000	2,038,000				605,000																																			2,129,000	2,752,000	2,951,000	954,000	1,055,000	1,161,000
manufacturing and development obligations – non-current																																5,748,000	5,996,000
investment in marketable equity securities																																					3,710,000	3,952,000	4,930,000	4,487,000	5,082,000	11,163,000	7,684,000
prepaid expenses																																		1,221,000				1,274,000	1,723,000	1,066,000	1,377,000	1,166,000	1,535,000	1,009,000	1,331,000	1,210,000	1,780,000	1,353,000	1,661,000	848,000	1,071,000	739,000	1,370,000	638,000				810,000
manufacturing and development obligations - current																																								2,221,000
deferred income taxes																																						150,000	140,000	140,000	131,000	122,000	127,000	122,000	116,000	115,000	108,000	102,000	95,000	89,000	82,000	75,000	69,000	62,000
deferred revenue - current																																								767,000			306,000		370,000
manufacturing and development obligations—current																																									2,219,000	3,282,000
debt—current																																									4,527,000	2,989,000		2,523,000						3,366,000				4,828,000				2,519,000
deferred revenue—current																																									613,000	554,000		577,000		376,000
debt—non-current																																									15,301,000	16,883,000		17,371,000		9,872,000		9,848,000						2,896,000				4,697,000
manufacturing and development obligations—non-current																																									4,840,000	4,542,000
total stockholders’ equity																																									83,534,000	94,765,000	95,521,000	110,529,000	109,937,000	41,521,000	47,276,000	44,208,000	44,867,000	42,795,000	35,646,000	54,945,000	60,788,000	19,107,000	16,916,000	18,519,000	19,308,000	18,313,000	16,168,000	13,245,000	19,119,000	23,732,000	12,308,000	12,078,000	16,988,000	21,448,000	25,822,000	21,593,000	27,362,000	34,278,000	39,604,000	47,812,000	56,008,000	59,887,000	69,162,000	77,605,000	94,999,000	100,971,000	73,166,000	74,102,000	78,221,000	35,275,000	38,768,000	40,334,000	42,866,000	21,489,000	26,999,000	31,983,000	43,464,000	62,694,000	76,569,000	39,175,000	71,920,000	83,152,000	94,149,000	119,607,000	131,562,000	66,675,000
warrant liability																																											2,424,000	3,978,000	4,189,000	10,485,000	3,931,000	7,653,000	11,356,000	20,390,000	22,706,000	10,290,000	10,976,000	5,903,000	7,876,000	8,749,000	12,440,000	7,979,000	4,643,000	10,082,000	9,743,000	8,465,000	5,073,000	4,352,000	3,699,000	2,737,000	2,800,000
accrued taxes																																											818,000	2,467,000
investment in aduro biotech, inc.																																												12,032,000
preferred stock, 0.001 par value 5,000 shares authorized, issuable in series; 0 shares issued and outstanding at december 31, 2013 and 2012
investments																																																			28,971,000
preferred stock, 0.001 par value 5,000 shares authorized, issuable in series; 0 and 3 shares issued and outstanding at december 31, 2012 and 2011; respectively, aggregate liquidation preference of 0 and 9,496 at december 31, 2012 and 2011, respectively
prepaid expenses and other current assets																																																							3,243,000	1,024,000	1,137,000						1,245,000	1,303,000			1,177,000	1,108,000
preferred stock																																																									9,496,000		9,496,000	9,496,000	9,496,000		9,496,000	9,496,000	9,496,000		9,496,000	9,496,000	9,496,000		9,496,000	9,496,000	9,496,000		9,496,000	9,496,000	9,496,000		9,496,000	9,496,000	9,496,000
debt — current																																																								3,692,000
debt — non-current																																																								3,717,000
capital lease obligations—current
capital lease obligations—non-current
preferred stock, 0.001 par value 5,000 shares authorized, issuable in series; 3 shares issued and outstanding at both december 31, 2011 and 2010; aggregate liquidation preference of 9,496 at december 31, 2011 and 2010																																																										9,496,000
current portion of long-term debt																																																												1,876,000	1,811,000	1,747,000	1,264,000	797,000	367,000
current portion of capital lease obligations																																																												11,000	10,000	10,000	10,000	9,000	9,000	9,000								30,000				84,000				67,000						3,000	7,000	28,000	34,000	36,000	34,000	33,000	31,000	30,000	29,000	29,000
long-term debt																																																											4,910,000	2,159,000	2,654,000	3,131,000	3,591,000	4,036,000	4,511,000
long-term portion of capital lease obligations																																																													3,000	6,000	8,000	11,000
purchased intangible																																																													1,899,000
non-current liabilities
stockholders’ equity
purchased intangibles																																																														1,950,000
accrued restructuring																																																																	24,000	113,000	209,000	361,000	652,000
preferred stock, 0.001 par value: 5,000 shares authorized, issuable in series; 3 shares issued and outstanding at december 31, 2010, and 2009; aggregate liquidation preference of 9,496 at december 31, 2010, and 2009																																																														9,496,000
long-term investment in related party																																																																			2,340,000	2,203,000	2,164,000	2,329,000	1,988,000	1,983,000	2,120,000	1,874,000	1,832,000	1,725,000	11,175,000
long term portion of capital lease obligations																																																																		15,000								2,000				32,000				68,000
other long-term liabilities																																																																		115,000				163,000
preferred stock, 0.001 par value: 5,000 shares authorized, issuable in series; 3 shares issued and outstanding at december 31, 2009, and 2008; aggregate liquidation preference of 9,496 at december 31, 2009, and 2008																																																																		9,496,000
capital lease obligations																																																																			8,000				9,000
preferred stock, 0.001 par value: 5,000 shares authorized, issuable in series; 3 shares issued and outstanding at december 31, 2008, and 2007; aggregate liquidation preference of 9,496 at december 31, 2008, and 2007																																																																						9,496,000
capital lease obligation																																																																								17,000	24,000		32,000	48,000	72,000		41,000	65,000	99,000
deferred gain																																																																													91,000	586,000	3,520,000	5,171,000	5,753,000
preferred stock, 0.001 par value: 5,000 shares authorized, issuable in series; 3 shares issued and outstanding at december 31, 2007, and 2006; aggregate liquidation preference of 9,496 at december 31, 2007, and 2006																																																																										9,496,000
accumulated other comprehensive																																																																																	-162,000
long-term investments																																																																														11,175,000	6,175,000	6,175,000	6,175,000	6,175,000				1,175,000	1,175,000
current loan and interest payable																																																																																		4,826,000
preferred stock, 0.001 par value: issuable in series; 3 shares issued and outstanding at december 31, 2006, and 2005; aggregate liquidation preference of 9,496 at december 31, 2006, and 2005																																																																														9,496,000
accounts receivable and other current assets																																																																															9,624,000	5,344,000	7,065,000	5,200,000	5,237,000	4,460,000	4,460,000	4,533,000	4,603,000	6,034,000	7,313,000	4,680,000	4,287,000	3,764,000
furniture and equipment, net of depreciation and amortization																																																																															1,517,000	1,559,000	1,547,000
current portion of capital lease obligation																																																																															100,000	102,000
inventory																																																																																	2,068,000
furniture and equipment at cost:
laboratory and office equipment																																																																																		6,306,000				5,768,000
leasehold improvements																																																																																		7,453,000				7,173,000
furniture and equipment at cost: - sum																																																																																		13,759,000				12,941,000
less accumulated depreciation and amortization																																																																																		12,524,000				11,994,000
net furniture and equipment																																																																																		1,235,000				947,000
accrued compensation and related expenses																																																																																		2,676,000				2,749,000
accrued contract and other expenses																																																																																		2,521,000
deferred gain on loan settlement																																																																																						22,089,000
long term debt payable to a related party																																																																																					4,557,000	4,500,000
preferred stock, 0.001 par value: issuable in series; 3 shares issued and outstanding at december 31, 2005, and 2004; aggregate liquidation preference of 9,496 at december 31, 2005, and 2004																																																																																		9,496,000
furniture and equipment, net of depreciation																																																																																			1,065,000	890,000	953,000		837,000	1,183,000	1,867,000	3,388,000	4,092,000	4,838,000	6,164,000	6,274,000	5,385,000	2,717,000	2,904,000	2,906,000
accounts payable to related party																																																																																			311,000
accrued expenses																																																																																			4,657,000	3,947,000	3,303,000		3,905,000	5,960,000	4,179,000	4,802,000	5,295,000	4,437,000	5,979,000	6,473,000	7,471,000	5,169,000	7,604,000	6,458,000
long-term debt and accrued interest																																																																																			4,736,000	4,646,000
accounts receivable from related parties																																																																																					47,000	4,000		59,000	29,000	25,000	6,000
accounts payable to a related party																																																																																						196,000	682,000	2,500,000	2,099,000	6,180,000	7,142,000	7,441,000	8,897,000	8,410,000	5,121,000	7,873,000	3,288,000	1,828,000
current loan and interest payable to a related party																																																																																						34,500,000
accrued contract research expenses																																																																																						587,000
other accrued expenses																																																																																						1,471,000
preferred stock, 0.001 par value: issuable in series; 3,327 shares issued and outstanding at december 31, 2004 and 2003; aggregate liquidation preference of 9,496 at december 31, 2004 and 2003																																																																																						9,496,000
accounts receivable from a related party																																																																																							15,000					21,000	55,000	5,028,000	28,000	63,000	149,000	177,000
loan and interest payable to a related party																																																																																							60,109,000	58,694,000	57,272,000	54,417,000
capital lease obligations, less current portion																																																																																												6,000	25,000	34,000	45,000	59,000	67,000	74,000
long-term debt, payable to a related party																																																																																											52,917,000	51,417,000
redeemable convertible preferred stock																																																																																														5,000,000	5,000,000	5,000,000	5,000,000	5,000,000

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-09-30	2003-06-30	2003-03-31	2002-09-30	2002-06-30	2002-03-31	2001-09-30	2001-06-30	2001-03-31

operating activities
net loss	-1,648,000	-2,184,000	-20,000	-5,715,000	-7,718,000	-2,562,000	-2,934,000	-5,775,000	-9,690,000	-1,389,000	-7,286,000	-13,331,000	-15,641,000	-13,625,000	-8,521,000	-8,395,000	-12,284,000	-9,121,000	-12,437,000	-15,361,000	-17,457,000	-14,381,000	-14,139,000	-14,871,000	-16,466,000	-16,923,000	-17,967,000	-17,562,000	-18,792,000	-16,205,000	-14,192,000	-13,282,000	-13,885,000	-11,486,000	-13,418,000	-17,083,000	-18,598,000	-13,501,000	-14,376,000	-18,166,000	-16,863,000	-14,756,000	-15,680,000	-15,972,000	-9,460,000	-20,182,000	-10,759,000	-7,589,000	-225,000	-5,860,000	-20,501,000	-6,724,000	-10,252,000	-1,716,000	-3,460,000	-1,907,000	-8,834,000	-7,997,000	2,338,000	-6,313,000	-5,010,000	-2,630,000	-3,832,000	-5,427,000	-5,022,000	-4,889,000	-5,637,000	-6,212,000	-7,397,000	-5,978,000	-8,818,000	-9,093,000	-5,292,000		-9,151,000											-5,352,000	-5,060,000	-11,547,000	-9,194,000	-14,208,000	-16,772,000	-17,159,000					-11,975,000	-11,165,000
adjustments to reconcile net loss to net cash from operating activities:
depreciation and amortization	447,000	393,000	382,000	344,000	307,000	332,000	412,000	480,000	631,000	647,000	677,000	640,000	635,000	649,000	708,000	762,000	865,000	812,000	765,000	777,000	794,000	811,000	810,000	782,000	706,000	622,000	-127,000	1,179,000	729,000	336,000	321,000	375,000	413,000	452,000	455,000	435,000	469,000	423,000	430,000	488,000	476,000	470,000	394,000	392,000	443,000	426,000	374,000	290,000	325,000	147,000	127,000	116,000	167,000	162,000	180,000	194,000	208,000	161,000	241,000	251,000	269,000	284,000	192,000	181,000	188,000	357,000	188,000	181,000	189,000	206,000	187,000	148,000	110,000	184,000	170,000	207,000	213,000	189,000	183,000	180,000	164,000	148,000	139,000	170,000	195,000	200,000	316,000	814,000	822,000	825,000	822,000	821,000	791,000	564,000	330,000	295,000	294,000	280,000
stock-based compensation	4,904,000	4,927,000	5,624,000	5,681,000	6,635,000	5,504,000	5,830,000	5,678,000	5,855,000	4,903,000	3,979,000	5,720,000	5,669,000	7,255,000	5,768,000	5,007,000	6,426,000	6,538,000	5,892,000	5,808,000	5,333,000	4,723,000	4,846,000	4,706,000	3,754,000	3,700,000	3,595,000	3,139,000	2,878,000	2,815,000	2,671,000	2,593,000	2,315,000	2,347,000	2,391,000	2,470,000	2,147,000	2,099,000	2,104,000	2,086,000	1,776,000	1,818,000	1,733,000	1,705,000	1,474,000	1,389,000	1,478,000	1,340,000	946,000	853,000	861,000	841,000	713,000	630,000	695,000	674,000	542,000	464,000	463,000	451,000	472,000	528,000	502,000			507,000	493,000																				127,000
non-cash operating lease cost	667,000	615,000	581,000	717,000	619,000	553,000	701,000	633,000	595,000	745,000	505,000	587,000	471,000	547,000	324,000	308,000	396,000	361,000	355,000	345,000	361,000	384,000	343,000	319,000	300,000
net loss on sale of available-for-sale securities	1,000	-11,000	3,000			3,000	-1,000	3,000	2,000					6,000	11,000	65,000	26,000					-22,000
unrealized loss on investments	105,000				40,000
non-cash interest expense	98,000	100,000	101,000	99,000	98,000	101,000	92,000	99,000	106,000	84,000	91,000	81,000	118,000	-831,000	519,000	457,000	464,000	468,000	299,000	377,000	104,000	120,000	121,000	118,000	119,000	43,000	96,000	50,000	197,000	356,000	355,000	268,000	269,000	269,000	-3,000	90,000	195,000	197,000	217,000	303,000	300,000	278,000	91,000	75,000	64,000	66,000							4,000	5,000	5,000	4,000	6,000			44,000	49,000	51,000	50,000
foreign currency remeasurement loss	-277,000	143,000	-361,000	11,000	497,000					711,000	-366,000	-263,000	-767,000	1,371,000	-31,000	284,000	287,000	125,000	189,000
changes in operating assets and liabilities:
accounts receivable	869,000	-608,000	1,438,000	-4,887,000	3,661,000	-5,624,000	-491,000	-1,219,000	12,838,000	-10,789,000	-2,477,000	3,007,000	9,157,000	-6,032,000	-1,324,000	-1,280,000	-564,000	-2,527,000	446,000	-5,047,000	2,913,000	-4,930,000	1,388,000	541,000	-1,283,000	-2,380,000	-1,070,000	324,000	-5,004,000	1,724,000	912,000	-899,000	1,926,000	-1,939,000	-1,886,000	-3,007,000	1,285,000	573,000	-2,292,000	-1,063,000	1,708,000	-148,000	-222,000	-271,000	340,000	1,873,000	-2,888,000	465,000	1,182,000	900,000	-1,157,000	-1,135,000	-289,000	-494,000	-225,000	1,297,000	1,074,000	-1,313,000	-363,000	380,000	-8,000	-1,280,000	-45,000	172,000	-14,000	-332,000	9,000	213,000	806,000	-34,000	259,000	296,000	139,000		1,517,000	911,000	-4,025,000		-3,906,000	5,934,000	-5,796,000
inventories	-5,815,000	-3,176,000	704,000	-5,877,000	-6,333,000	-990,000	1,742,000	4,684,000	1,594,000	4,572,000	-8,174,000	-5,349,000	-5,996,000	751,000	203,000	-1,888,000	-834,000	-7,480,000	-4,124,000	-6,970,000	-1,036,000	-3,955,000	-1,037,000	3,188,000	-2,226,000	1,416,000	-3,482,000	-1,691,000	-2,286,000	-237,000	-415,000	234,000	1,224,000	-292,000	-2,037,000	625,000	-388,000	-349,000	-114,000	-830,000	-488,000	2,021,000	858,000	2,332,000	-1,220,000	3,665,000	779,000	-2,528,000	1,117,000	-468,000	-4,000	283,000	-1,624,000	-502,000	-309,000	-470,000	-2,459,000	3,147,000	377,000	-842,000	-3,169,000	1,377,000	-797,000	557,000	883,000	647,000	1,366,000	1,350,000	4,000	-801,000	1,683,000	-2,468,000	-2,461,000	-3,119,000	147,000	-1,513,000	-744,000		60,000
prepaid and other assets	542,000	442,000	-1,258,000	1,501,000	-2,312,000	-837,000	-1,150,000	-919,000	-119,000	515,000	-1,739,000	1,665,000	-1,435,000	-341,000	-168,000
accounts payable	4,141,000	2,363,000	-4,480,000	2,805,000	5,037,000	6,348,000	-1,004,000	-683,000	-6,138,000	-15,424,000	1,556,000	1,702,000	4,831,000	465,000	643,000	-1,892,000	-4,121,000	9,707,000	-4,892,000	8,939,000	-1,550,000	4,992,000	430,000	-878,000	-2,308,000	2,012,000	-224,000	632,000	2,597,000	2,663,000	2,866,000	276,000	-122,000	-1,535,000	2,937,000	887,000	198,000	1,699,000	-340,000	907,000	995,000	-781,000	1,091,000	-4,660,000	484,000	582,000	1,070,000	-444,000	-2,181,000	1,598,000	-959,000	1,148,000	-3,299,000	1,486,000	2,192,000	-642,000	-530,000	900,000	-902,000	-549,000	2,001,000
accrued liabilities and other non-current liabilities	-7,529,000	4,209,000	-787,000	3,279,000	-2,426,000	2,688,000	235,000	-1,531,000	-3,590,000	-724,000	1,559,000	-3,309,000	-6,596,000	6,878,000	-81,000	534,000	-8,594,000	-1,469,000	2,567,000	3,155,000	-4,863,000	4,674,000	2,730,000	-288,000	-4,356,000	2,672,000	2,033,000	1,399,000	-4,809,000	1,585,000	3,904,000	1,894,000	-1,341,000	970,000
deferred revenue	446,000	-1,007,000	70,000	-238,000	1,051,000	-423,000	726,000	-1,071,000	165,000																															137,000	52,000	232,000	-298,000	233,000	23,000	-110,000	294,000	-13,000	98,000	70,000	-42,000	-21,000	97,000	-639,000	580,000	-61,000	86,000	37,000	-49,000	-38,000	-87,000	15,000	21,000	-163,000	30,000	42,000	-356,000	249,000	-35,000	360,000	25,000	-229,000	-1,215,000	1,465,000	7,000	-94,000	126,000	2,946,000	-2,053,000	-3,465,000	-3,563,000					9,566,000	2,106,000	943,000	27,000							229,000	-27,000	964,000
net cash from operating activities	-3,049,000	6,200,000	1,927,000	-2,446,000	-844,000	4,929,000	4,070,000	401,000	1,959,000	-15,183,000	-10,489,000	-8,996,000	-8,500,000	-1,756,000	-2,058,000	-345,000	-21,456,000	-1,222,000	-6,582,000	-8,142,000	-17,976,000	-8,458,000	-4,679,000	-7,804,000	-19,802,000	-8,561,000	-22,217,000	-12,882,000	-22,178,000	-7,095,000	-4,896,000	-8,930,000	-10,325,000	-10,035,000	-12,853,000	-12,999,000	-16,348,000	-9,711,000	-16,251,000	-14,524,000	-13,043,000	-8,785,000	-11,860,000	-14,733,000	-15,751,000	-8,634,000	-11,741,000	-9,611,000	-9,825,000	-6,664,000	-6,092,000	-5,689,000	-8,352,000	-2,875,000	-1,752,000	-5,386,000	-3,904,000	-1,146,000	-3,449,000	-5,979,000	-5,058,000	-4,365,000	-1,901,000	-2,005,000	-5,840,000	-2,837,000	-2,333,000	-2,486,000	-7,008,000	-6,458,000	-9,526,000	-7,862,000	-10,699,000	-12,745,000	-5,648,000	-5,048,000	-13,961,000	-307,000	-6,624,000	-6,239,000	-1,515,000																	-10,861,000
investing activities
capital expenditures	-233,000	-1,307,000	-1,833,000	-477,000	-112,000	-976,000	-721,000	-41,000	-1,099,000	6,000	-2,635,000	-444,000	-1,524,000	-1,235,000	-574,000	-78,000	-113,000	-464,000	-221,000	-32,000	-193,000	-466,000	-242,000	-455,000	-452,000	-475,000	-1,944,000	-3,201,000	-3,315,000	-520,000	-479,000	-93,000	-52,000	1,000	-1,000	-168,000	-185,000	-204,000	-241,000	-75,000	-43,000	-161,000	-236,000	-266,000	-59,000	-73,000	-604,000	-590,000	-839,000	-223,000	-260,000	-154,000	-26,000	16,000	-34,000	-61,000	-2,000	0	0	0	-51,000	-106,000	-806,000	-735,000	-62,000	0	-40,000	-43,000	-57,000	0	2,000	-466,000	-220,000	0	-116,000	-108,000	-136,000	0	-141,000	-489,000	-179,000																	-192,000
free cash flows	-3,282,000	4,893,000	94,000	-2,923,000	-956,000	3,953,000	3,349,000	360,000	860,000	-15,177,000	-13,124,000	-9,440,000	-10,024,000	-2,991,000	-2,632,000	-423,000	-21,569,000	-1,686,000	-6,803,000	-8,174,000	-18,169,000	-8,924,000	-4,921,000	-8,259,000	-20,254,000	-9,036,000	-24,161,000	-16,083,000	-25,493,000	-7,615,000	-5,375,000	-9,023,000	-10,377,000	-10,034,000	-12,854,000	-13,167,000	-16,533,000	-9,915,000	-16,492,000	-14,599,000	-13,086,000	-8,946,000	-12,096,000	-14,999,000	-15,810,000	-8,707,000	-12,345,000	-10,201,000	-10,664,000	-6,887,000	-6,352,000	-5,843,000	-8,378,000	-2,859,000	-1,786,000	-5,447,000	-3,906,000	-1,146,000	-3,449,000	-5,979,000	-5,109,000	-4,471,000	-2,707,000	-2,740,000	-5,902,000	-2,837,000	-2,373,000	-2,529,000	-7,065,000	-6,458,000	-9,524,000	-8,328,000	-10,919,000	-12,745,000	-5,764,000	-5,156,000	-14,097,000	-307,000	-6,765,000	-6,728,000	-1,694,000																	-11,053,000
purchases of investments	-8,410,000	-15,012,000	-7,288,000	-12,513,000	-7,964,000	-24,234,000	-5,645,000	-12,977,000	-119,000	-82,000	-53,000	-1,789,000	-562,000	-6,983,000	-9,441,000	-12,574,000	-642,000	-49,934,000	-106,000	-111,000	-1,915,000	-4,765,000	-17,157,000	-8,351,000	-68,520,000	-9,151,000	-7,028,000	-26,728,000	-1,000,000	-248,000	-4,991,000	-18,521,000	-56,941,000	-18,609,000	-29,434,000	-10,591,000	-10,158,000	-11,051,000	-1,200,000	-20,016,000	-50,544,000	-12,146,000	-8,278,000	-1,000	-69,982,000	-11,174,000
proceeds from maturities and sale of investments	18,503,000	14,941,000	6,612,000	11,901,000	6,887,000	17,924,000	11,183,000	5,911,000	2,664,000	8,292,000	2,413,000	4,562,000	440,000	15,601,000	7,949,000	7,177,000	9,377,000	10,108,000	22,056,000	10,000,000	23,500,000	12,833,000	12,019,000	7,211,000	18,787,000	19,027,000	19,000,000	25,500,000	17,500,000	7,995,000	6,000,000	11,752,000	12,250,000	14,000,000	17,101,000	22,447,000	16,018,000
net cash from investing activities	9,860,000	-1,378,000	-2,509,000	-1,089,000	-1,189,000	-7,286,000	4,817,000	-7,107,000	1,446,000	8,216,000	-275,000	2,329,000	-1,646,000	7,383,000	-2,066,000	-5,475,000	8,622,000	-40,290,000	21,729,000	9,857,000	21,392,000	7,602,000	-5,380,000	-1,595,000	-50,185,000	9,401,000	10,028,000	-4,429,000	13,185,000	7,227,000	530,000	-6,862,000	-44,743,000	-4,608,000	-12,334,000	11,688,000	5,675,000	18,661,000	12,556,000	-6,092,000	-45,049,000	22,905,000	26,485,000	17,616,000	-65,594,000	-3,862,000	-4,863,000	2,377,000	3,001,000	559,000	-29,423,000	-167,000	-26,000	14,000	-35,000	30,000	196,000	273,000	109,000	18,000	163,000	724,000	-515,000	-705,000	409,000	651,000	1,851,000	3,293,000	3,645,000	1,491,000	2,362,000	7,933,000	12,107,000	-6,287,000	9,869,000	-873,000	6,593,000	-20,412,000	-7,666,000	10,201,000	9,937,000	4,070,000	3,094,000	3,800,000	4,400,000	25,321,000			13,006,000			712,000					1,677,000	7,295,000
financing activities
net proceeds from equity incentives	263,000	0	269,000	0	326,000	0	363,000	0	441,000	0	433,000	0	492,000	490,000	1,082,000	377,000	2,135,000	4,285,000	2,991,000	876,000	1,218,000	4,766,000	4,187,000	1,604,000	1,193,000	356,000	1,584,000	560,000	710,000	698,000	2,238,000	3,617,000	1,295,000		369,000	1,630,000	422,000														404,000
net costs from public offerings		0	52,000	-31,000	-56,000	-30,000	-42,000				0	-65,000	-72,000
net proceeds from revolving line of credit	929,000				801,000																					24,000	497,000
net cash from financing activities	1,192,000	-1,031,000	320,000	-129,000	1,071,000	746,000	60,000	-1,403,000	5,561,000	1,183,000	7,602,000	-173,000	2,061,000	457,000	1,084,000	202,000	2,449,000	12,098,000	4,581,000	127,000	17,488,000	8,287,000	4,171,000	10,641,000	68,684,000	9,484,000	13,066,000	11,804,000	9,133,000	6,399,000	12,388,000	15,137,000	58,827,000	11,332,000	21,902,000	10,645,000	-879,000	302,000	8,871,000	7,529,000	7,865,000	6,103,000	1,111,000	14,242,000	76,498,000	12,934,000	10,385,000	11,804,000	1,331,000	11,235,000	1,669,000	-5,106,000	50,845,000	2,896,000	1,781,000	574,000	9,660,000	11,609,000	934,000	-471,000	-454,000	20,705,000	161,000	36,000	4,957,000	7,000	12,158,000	0	43,000	-36,000	65,000	591,000	710,000	671,000	478,000	16,000	273,000	24,440,000	160,000	-53,000	38,585,000					0	93,000	-4,000	118,000	327,000						764,000	76,435,000	907,000
effect of exchange rates on cash, cash equivalents, and restricted cash	-122,000	0	-60,000	210,000	186,000	-237,000	152,000	-16,000	-90,000	-16,000	-107,000	-121,000	116,000	401,000	-410,000	-434,000	-284,000	-280,000	-276,000
net increase in cash, cash equivalents, and restricted cash	7,881,000	3,791,000	-322,000	-3,454,000	-776,000	-1,848,000	9,099,000	-8,125,000	8,876,000					6,485,000	-3,450,000
cash, cash equivalents, and restricted cash, beginning of period	20,600,000	0	0	0	21,361,000	0	0	0	13,359,000	0	0	0	37,358,000	0	0
cash, cash equivalents, and restricted cash, end of period	28,481,000	3,791,000	-322,000	-3,454,000	20,585,000	-1,848,000	9,099,000	-8,125,000	22,235,000	-5,800,000	-3,269,000	-6,961,000	29,389,000	6,485,000	-3,450,000
unrealized gain on investments		-6,000	-70,000			83,000	-108,000	6,000	-116,000	-169,000	114,000	-62,000	-53,000	-80,000	103,000	233,000	-820,000	-25,000	7,000	-41,000	-208,000
loss on disposal of fixed assets						0	0	0	3,000																																					0
impairment charges for facilities consolidation										0	1,493,000
net (payments on) proceeds from revolving line of credit
proceeds from loans, net of issuance costs									5,000,000
supplemental disclosure of cash flow information:
cash paid for interest																																																		52,000	39,000	125,000	78,000	130,000	126,000	121,000	83,000	189,000	434,000	239,000	162,000	226,000	225,000
cash paid for income taxes																																																					26,000
net proceeds from (payment on) revolving line of credit			-1,000
changes in valuation of warrant investment															9,000	-45,000	281,000	337,000	-83,000	-182,000	-220,000
foreign currency remeasurement gain							20,000	16,000	-177,000
net (payment on) proceeds from revolving line of credit																							32,000
proceeds from loans							0											0	0	0	15,000,000					0	0							0
debt issuance costs											-68,000
net (payment on) proceeds on revolving line of credit
net proceeds on revolving line of credit									120,000	1,221,000	2,237,000	-1,458,000	3,091,000	29,000	-50,000	-81,000	314,000	4,711,000	657,000	-609,000	1,422,000
loss, net on sale of available-for-sale securities
impairment of long-lived assets															0	0	542,000
net (costs) proceeds from public offerings
contribution from noncontrolling interest																		0
net gain on sale of available-for-sale securities											4,000	43,000	3,000
deferred product revenue											-425,000	-332,000	1,104,000	-165,000	-221,000	-283,000	585,000	-71,000	-127,000	-185,000	479,000	16,000	-145,000	-436,000	572,000	9,000	-104,000	-98,000	265,000	-35,000	-143,000	30,000	186,000	-249,000	281,000	-80,000	313,000	-751,000
net decrease in cash, cash equivalents, and restricted cash											-3,269,000	-6,961,000	-7,969,000
repayment of loans													-1,450,000
impairment (unrealized gain) in private company investment
offering costs from public offerings															52,000
other assets																	-4,111,000	729,000	4,589,000	46,000	-2,626,000	-742,000	-21,000	-979,000	1,119,000	-89,000	59,000	-348,000	2,165,000	-20,000	-1,137,000	-112,000	-1,475,000	1,486,000	-1,083,000	1,014,000	-310,000	973,000	-81,000	648,000	-213,000	577,000	63,000	855,000	-116,000	1,205,000	-2,410,000	314,000	-764,000	185,000	-338,000	-418,000	910,000	343,000	-1,992,000	110,000	-124,000	72,000	-218,000	326,000	-193,000	248,000	59,000	-262,000	54,000	26,000	-191,000	236,000	74,000	-696,000	217,000	299,000	752,000	-1,532,000	-225,000	222,000	544,000	651,000	-376,000	-4,209,000	3,907,000	-161,000				-61,000	0	107,000	25,000									1,000
net increase in cash, cash equivalents and restricted cash																	-10,669,000	-29,694,000	19,452,000	1,479,000	20,904,000				-1,303,000	10,324,000	877,000	-5,507,000	140,000	6,531,000	8,022,000	-655,000	3,759,000
cash, cash equivalents and restricted cash, beginning of period																	51,044,000	0	0	0	38,903,000	0	0	0	37,421,000	0	0	0	31,587,000		0	0	13,930,000		0	0	22,744,000
cash, cash equivalents and restricted cash, end of period																	40,375,000	-29,694,000	19,452,000	1,479,000	59,807,000	7,431,000	-5,888,000	1,242,000	36,118,000	10,324,000	877,000	-5,507,000	31,727,000		8,022,000	-655,000	17,689,000		-3,285,000	9,334,000	11,192,000
loss on disposal of property and equipment																										1,000	0			0	0
manufacturing and development obligations																										0	-6,250,000	80,000	-118,000	-79,000	-39,000	-312,000	164,000	80,000	181,000	343,000	76,000	-310,000	-2,176,000	-158,000	-924,000
net proceeds from public offerings																						-13,000	-48,000	8,900,000	67,695,000
non-cash investing activities:
non-cash leasehold improvements
loss on sale of available-for-sale securities																								-6,000	267,000
net (offering costs) proceeds from public offerings																			-67,000
net (payments for) proceeds from public offerings																					-152,000
repayment of debt																										-24,000	-35,000	-35,000	-31,010,000	-34,000	-34,000	-33,000	-32,000	-32,000	-17,663,000	-659,000	-1,271,000	-31,000	-531,000	-28,000	-32,000	-28,000	-29,000	-28,000	-28,000
net decrease in cash, cash equivalents and restricted cash																						7,431,000	-5,888,000												-3,285,000	9,334,000	-11,552,000
net payment on revolving line of credit																									-204,000
non-cash tax expense from realized gain on available-for-sale securities
gain on sale of investment in marketable equity securities																																		0	0	-3,448,000	-18,000
net proceeds from public offering																										9,128,000	11,020,000			5,735,000	10,184,000			11,357,000	9,196,000			-25,000	7,599,000	7,348,000	7,199,000	-27,000	3,000	-203,000	75,527,000	11,639,000	3,002,000	3,816,000	31,000	10,444,000	-190,000	-331,000	51,502,000	3,403,000	947,000	264,000	9,612,000
non-cash purchases of capital expenditures
non-cash lease expense
proceeds from loans, net of discount																													39,433,000														0
deferred income taxes																														2,000	1,000	0	1,000	-138,000	7,000	5,000	7,000	10,000	0	9,000	9,000	-5,000	5,000	6,000	1,000	7,000	6,000	7,000	6,000	7,000	7,000	6,000	7,000
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
non-cash tax expense from other realized gain on available-for-sale securities
non-cash tax expense from other unrealized loss on available-for-sale securities																																			0				-456,000	934,000	768,000
net proceeds from (payments for) public offering																																	57,564,000
changes in valuation of warrant liability
non-cash deferred manufacturing and development expense
non-cash tax expense from other unrealized gain on available-for-sale securities
net proceeds from equity incentives and warrants																																						358,000	1,803,000
supplemental disclosures:
unpaid manufacturing and development obligation
bad debt expense
accrued liabilities																																				267,000	-1,724,000	1,072,000	716,000	181,000	-639,000	1,734,000	1,163,000	-50,000	-1,488,000	-4,110,000	1,985,000	2,038,000	-1,295,000	-2,327,000	3,458,000	905,000	85,000	-248,000	1,456,000	-911,000	1,674,000	136,000	200,000	-21,000	-651,000
net (payments for) proceeds from public offering																																					-30,000
non-cash tax benefit from other unrealized gain on available-for-sale securities
proceeds from sale of fixed assets
proceeds from maturities of investments																																							14,000,000	14,000,000	5,500,000	35,201,000	35,000,000			7,610,000
restricted cash																																							-3,000	-1,000	38,000	11,000	-1,000	-161,000	47,000
net increase in cash and cash equivalents																																							5,176,000			20,223,000	15,736,000	17,125,000	-4,847,000			4,570,000	-5,493,000	5,130,000	-33,846,000	-10,962,000	42,467,000	35,000	-6,000	-4,782,000	5,952,000					17,064,000				-2,179,000	11,676,000					662,000	2,118,000	-18,361,000	4,699,000	-5,905,000	-7,095,000				47,007,000								2,578,000	-39,950,000						-39,067,000
cash and cash equivalents, beginning of period																																							0				0	0	22,781,000		0	0	29,485,000	0	0	0	26,696,000	0	0	0	25,497,000	0	0	0	28,948,000	0	0	0	17,287,000	0	0	0	10,303,000	0	0	0	19,625,000	0	0	0	46,287,000	0	0	0	5,780,000	-324,000	0	0	39,493,000	0	0	0	23,165,000	0	0	22,435,000	0	0	64,503,000	0	0	71,871,000
cash and cash equivalents, end of period																																							5,176,000				15,736,000	17,125,000	17,934,000		-6,219,000	4,570,000	23,992,000	5,130,000	-33,846,000	-10,962,000	69,163,000	35,000	-6,000	-4,782,000	31,449,000	10,736,000	-2,406,000	-6,432,000	23,599,000	17,064,000	-2,255,000	-2,674,000	16,813,000	-2,179,000	11,676,000	807,000	6,983,000	-5,003,000	-7,099,000	662,000	21,743,000	-18,361,000	4,699,000	-5,905,000	39,192,000	3,721,000	-14,130,000	3,909,000	52,787,000	375,000	472,000	97,000	4,836,000	31,555,000	-286,000	-17,843,000	25,743,000	-39,950,000	37,481,000	55,347,000	15,637,000	-21,465,000	47,956,000	-39,067,000	69,156,000	69,212,000
net proceeds from the issuance of common stock in connection with equity incentive plans																																									698,000
net decrease in cash and cash equivalents																																									-50,227,000																		-2,406,000	-6,432,000	-5,349,000			-2,674,000	-474,000				-3,320,000
cash and cash equivalents, beginning of year																																									71,018,000
cash and cash equivalents, end of year																																									20,791,000
tax benefit from other unrealized gain on available-for-sale securities																																										-1,791,000	51,000
net proceeds from exercise/purchase of equity incentives and warrants
proceeds from debt, net of discount
non-cash settlement of warranty claim																																																		0	0
gain from revaluation of warrant liability
proceeds from sales of certain other assets
net proceeds from equity incentive plans and warrants																																											1,137,000
changes in revaluation of warrant liability																																												2,707,000	-6,296,000		-1,738,000	-3,491,000	-9,034,000		12,416,000	-686,000	5,073,000	-1,973,000	-873,000
proceds from maturities of investments																																													4,400,000
net proceeds from equity incentive plans																																													999,000				1,425,000				152,000				77,000
non-cash conversion of preferred stock to common stock																																																						0	0
proceeds from sales (purchases) of certain assets and other
net proceeds from equity incentives and exercise of warrants																																															7,410,000
proceeds from term loan, net of discount and revolving line of credit																																															0
payments on debt, revolving line of credit and landlord provided leasehold incentives																																															-27,000	-3,294,000	-125,000				-1,335,000
changes in operating assets and liabilities, net of effects of acquired business:
purchases of investments and certain other assets																																																-3,032,000	-460,000
maturities of investments																																																5,999,000	4,300,000					0	0	87,000	200,000	169,000	156,000	123,000	218,000
proceeds from revolving line of credit																																																		1,094,000	1,482,000	0	526,000	591,000	1,044,000
changes in valuation of outstanding warrant liability
(interest expense paid) non-cash interest expense
loss on disposal of equipment																																																		-40,000
purchases of furniture, equipment and leasehold improvements																																																		-223,000	-260,000	-154,000	-26,000	16,000	-34,000	-61,000	-2,000				-51,000	-106,000	-806,000	-735,000	-62,000		-40,000	-43,000	-57,000		2,000	-466,000	-220,000		-116,000	-108,000	-136,000		-141,000	-489,000	-179,000																	-192,000
(purchases) sales of certain other assets																																																		-1,000	-1,000
net proceeds from equity incentives and the exercise of warrants																																																						34,000
payments on revolving line of credit																																																						-684,000
payments on debt and landlord provided leasehold incentives																																																		1,534,000	-27,000			-448,000	-29,000	-31,000	-29,000
(purchases) maturities of investments
proceeds from warrant exercises
loss on disposal																																																				0	56,000
purchases of certain other assets																																																									-2,000
gain on non-controlling equity interest
accrued restructuring																																																														0	0	-24,000	-89,000		-152,000	-291,000	652,000
sales (purchases) of certain other assets
sales of investments
proceeds from landlord provided leasehold incentives
common stock issued in connection with the acquisition of certain assets of bioone
gain on sale of fixed assets																																																							-1,000	0	-8,000
purchases (sales) of certain other assets																																																							-1,000
loss from revaluation of warrant liability																																																									4,461,000		-5,439,000						962,000
loss on sale of fixed assets																																																										-94,000			-9,000	7,000	17,000
impairment of long-term investment in related party																																																																										107,000	-107,000
gain from operating settlement
purchase of furniture, equipment and leasehold improvements																																																											-47,000
purchase of certain other assets																																																											0
net proceeds from issuance of common stock due to exercise of stock options and purchase from espp																																																											122,000
proceeds from note payable, net of discount																																																														23,000	3,000
payments on capital lease obligations and notes																																																											-4,098,000				-2,000
other-than-temporary loss on marketable securities
revaluation of warrant liability																																																													1,278,000
net decrease in other assets																																																													-4,000
net proceeds from issuance of common stock and, exercise of stock options and purchases from espp																																																													10,000
payments on capital lease and loan obligations																																																													-464,000
revaluation of warrant																																																														-2,375,000
(purchases)/sales of other assets
net proceeds from issuance of common stock due to exercise of stock options and purchases from espp
issuance cost for credit facility																																																																						0	0
operating activities:
accounts payable and accrued expenses																																																															1,246,000	1,757,000	-3,204,000		1,947,000	1,208,000	-1,876,000		-3,634,000	2,779,000	-3,355,000		1,678,000	3,264,000	-3,295,000		2,312,000	16,000	702,000														436,000		748,000	-419,000
investing activities:
increase in other assets
sale of short-term investments
maturities of marketable securities																																																															323,000
financing activities:
net proceeds from issuance of common stock and exercise of stock options
non-cash asset acquisition
purchases and refunds of long-term investments and other assets
net proceeds from issuance of common stock, and exercise of stock options
stock-based compensation to employees																																																																	325,000				575,000		555,000	406,000	623,000		316,000	511,000	523,000		595,000	786,000	642,000	107,000	0	0	99,000
unrealized loss on available for sale securities																																																																	47,000
maturities of short-term investments																																																																	471,000	702,000	1,891,000	3,336,000	3,702,000	1,936,000	6,355,000	1,166,000	12,824,000	10,279,000	22,175,000	6,242,000	14,186,000	295,000	7,926,000	17,141,000	10,116,000	4,258,000	5,407,000	-96,000	3,600,000	-386,000	1,589,000	2,321,000	7,942,000	10,932,000	26,916,000	23,133,000	15,540,000	12,866,000	20,886,000	5,611,000	4,976,000	8,475,000
net proceeds from issuance of common stock, espp, stock options and restricted stock units																																																																	190,000				43,000			499,000	717,000				290,000
payments on capital lease obligations																																																																	-44,000	-3,000				-9,000	-8,000	-8,000	-7,000	-5,000	-28,000	-34,000	-17,000	58,000	-24,000	-55,000	-15,000																	-12,000
proceeds from issuance of notes payable																																																																	4,811,000
unrealized loss on securities
loss on sale of equipment
deferred gain																																																																										0	0	-91,000	-495,000		-1,651,000	-582,000	5,753,000
purchases of furniture and equipment
purchases of short-term investments																																																																						0	0	-988,000	-1,297,000	-17,827,000	-11,402,000	-7,795,000	-7,457,000	-20,408,000	-15,451,000																			-988,000
sales of short-term investments																																																																						65,000	-3,995,000	8,221,000	800,000										0	2,000,000	6,000,000		12,000,000	20,700,000	37,000,000	18,000,000	3,000,000	18,000,000	27,000,000	11,033,000	9,000,000
net proceeds from issuance of common stock																																																																																		288,000	189,000	102,000	114,000	0	96,000	0	130,000	333,000	54,166,000	165,000	326,000	287,000	941,000	771,000	76,442,000	919,000
proceed from note payable
gain on sales of fixed assets																																																																			0
net proceeds from issuance of common stock, espp, and stock options																																																																			25,000
proceeds from public offering
proceeds from note payable																																																																							-1,000
non-cash equity received in satisfaction of milestone and development funding
loan repayments
net income																																																																													-6,808,000	3,010,000	-1,788,000	-5,071,000	-930,000	-3,894,000	-1,666,000	-2,761,000	21,385,000										-13,547,000
adjustments to reconcile net income to net cash from operating activities:
gain on settlement of loan
accounts receivable and other current assets																																																																																				4,000	73,000	70,000
proceeds from sale of equipment
accrued interest																																																																															0	0	-326,000		90,000	89,000	57,000		1,495,000	1,498,000	1,500,000	1,500,000	1,500,000	1,417,000
net proceeds from issuance of common stock in public offering
repayment of loan																																																																															0	0	-4,500,000
net proceeds from issuance of common stock public offering																																																																																	42,353,000
non-cash equity in satisfaction of milestone and development funding
gain on sale of equipment																																																																																						8,000
loss on long-term investment
accrued interest payable
accrued compensation and related expenses
accrued contract research and other accrued expenses
investments in bioone corporation
gain on loan settlement
net proceeds from common stock public offering																																																																															19,000
net proceeds from issuance of common stock from espp, stock options and restricted stock units																																																																															165,000
increase in cash and cash equivalents																																																																															-14,130,000
inventory																																																																																	-2,068,000
net proceeds from issuance of common stock espp, stock options and restricted stock units																																																																																	747,000
stock-based compensation to consultants																																																																																			0	0	1,000	11,000
accrued contract research expenses
other accrued expenses
loan proceeds
net cash used in operating activities
investment in bioone corporation common stock
accounts receivable from a related party applied to loan payable to a related party																																																																																							80,000	76,000	62,000
accounts receivable from a related party																																																																																										-19,000	15,000	25,000
accounts payable to a related party																																																																																													487,000	3,289,000	92,000	4,585,000	1,460,000	37,000
issuance of common stock for services																																																																																																0
accrued interest payable to a related party
proceeds from loan payable to a related party
interest paid
investment in bioone corporation
proceeds from loan																																																																																											0	50,000,000
net cash provided by financing activities																																																																																												50,156,000	318,000	278,000	935,000
net increase (decrease) in cash and cash equivalents																																																																																												32,912,000						-2,659,000
other current assets																																																																																																		-649,000
net cash provided by investing activities
amortization of deferred compensation
accrued cash dividend on preferred stock, payable to a related party
accounts receivable from related a party																																																																																																86,000	28,000	90,000
net cash from (used in) investing activities
repurchase of common stock

Cerus Corporation(NASDAQ:CERS)

Cerus Corporation
(NASDAQ:CERS)